Category: Metabolic health

  • Dr. Gurpreet Singh Padda presenting beside the title card Your Sugar Craving Has a Schedule, The Angry Gut, Chapter 24

    What Causes Sugar Cravings? The Numbers a Scale Cannot Show

    Your Sugar Craving Has a Schedule | The Angry Gut, Chapter 24

    What Causes Sugar Cravings? The Numbers a Scale Cannot Show

    Sugar cravings come mainly from what you have been eating and the signals your gut sends, not from character: on an ultra-processed menu, adults ate about 508 more calories a day, and eight weeks of a daily high-fat, high-sugar snack rewrote food preferences with no change in weight.

    A craving that shows up at four in the afternoon and again after nine is not random. Anything that keeps a timetable has machinery behind it, and part of that machinery can be measured.

    Ask most people what causes sugar cravings and the answer comes back as a verdict on character. The research points somewhere less insulting and far more useful. What you have been eating rewrites what you want, the first brain in your gut files a report on every meal with the second brain in your skull, and the metabolic cost can pile up while your weight sits still. That last part is a measuring problem. If the bathroom scale is the only number anyone checks, the changes that matter most never get recorded. The video Your Sugar Craving Has a Schedule traces the gut route; the question here is what could actually be put on paper for you.

    What causes sugar cravings that keep a timetable

    The pattern described in The Angry Gut is precise. The pull arrives late in the afternoon and again at night. It wants sweet and starchy food and almost never protein. It fades after a couple of weeks of better eating, then returns within days of one bad weekend. A character trait does not switch on and off like that. A system answering to its recent diet does.

    A controlled ward study shows how strong the food effect is. Twenty adults were admitted and offered either ultra-processed or unprocessed meals that matched on everything a label lists, then allowed to eat as much as they liked. On the ultra-processed menu they took in roughly 508 more calories every day. Their weight went up 0.9 kg over two weeks and came back down when the menu changed. Nothing about the people changed between those two weeks. Only the food did.

    Why can appetite change before your weight does?

    A second experiment is the one that should retire the willpower speech for good. Adults of normal weight ate a daily high-fat, high-sugar snack for eight weeks. Afterward they liked low-fat food less and their brains reacted more strongly to food cues, and none of that tracked their body weight or the metabolic markers the team followed. The appetite had been rewritten with nothing to show for it on a scale.

    A sweetener trial adds a second warning. Forty-five adults who did not usually drink sweeteners had a series of sweetened drinks. Sucralose on its own left insulin sensitivity alone. Sucralose arriving together with a carbohydrate lowered it. The gut judged what was delivered, not what the taste promised. In a small teenage arm that was halted for safety, HOMA-IR, a blood-based estimate of insulin resistance, jumped past 12.9 from a starting point under 3.5 in two of the three participants. That is too few people to call a result, and it leans the same way as the adult data.

    I told patients for years to eat less and try harder, and I thought that was help. I was handing an instruction to an organ that does not take instructions. The snack study changed my mind because preference moved while the scale did not.

    What does a routine checkup miss about sugar cravings?

    A standard visit usually records weight and blood pressure and may add a glucose check. Those numbers are worth having. They were also not where the changes above showed up. The snack study moved appetite and brain response with weight flat, and the sweetener study moved insulin sensitivity in about ten days, a shift no scale can register.

    Food addiction, the label many people with cravings are handed, is scored with a questionnaire. Pooled across 272 studies, about 20% of people meet its criteria, rising to 55% among people already diagnosed with binge eating. There is no blood test behind that score, and researchers still disagree about whether it names a disease at all.

    Then there is the driver no lab report prints. Refined carbohydrate is the cheapest calorie on the shelf because farm policy made it cheap, and it is built to win the exact contest those studies measured. The exposure is subsidized, and the patient is billed for a personality defect.

    What can testing show about sugar cravings?

    Measura [Cardiometabolic and Autonomic Health Analysis] does not test gut bacteria, does not score food addiction and does not treat cravings. It measures, and the results go to your physician. Three measurements fit the questions a scheduled craving raises.

    • Laboratory panels can look at glucose and insulin together, so the question becomes how hard your body is working to keep sugar in range, not only whether it is high yet. More on that terrain is in insulin resistance and metabolic health.
    • Indirect calorimetry measures the energy you burn at rest from the air you breathe, instead of guessing it from a formula. When a ward study finds hundreds of extra calories eaten on processed food, your own measured burn turns a vague argument into arithmetic. See measured versus estimated metabolic rate.
    • Heart rate variability records beat-to-beat variation that reflects autonomic balance. The vagus nerve carries gut signals toward the brainstem, but this measure does not read cravings. It gives a baseline for the nervous system those signals travel through.

    Where the gut bacteria fit, and where the proof ends

    The bold claim is that gut microbes steer your appetite. In humans, the firmest finding is about one bacterial product. Propionate, a fatty acid bacteria make from fiber, was delivered directly to the colon in healthy men, and their intake at a buffet-style meal fell 9.5% while a reward region of the brain cooled toward pictures of high-calorie food. Feeding bacteria 30 g of inulin a day in 59 overweight adults also quieted reward regions, but the planned eating outcome came out null.

    No human study has shown a defined microbial change producing a craving. Among 105 women, food addiction scores lined up with obesity and with four bacterial genera, at one moment in time. That is mechanism and association, stated as such, and it is still the best guide for real patients who arrive with insulin resistance, poor sleep and a medication list that would bar them from any tidy trial. The practical lever does not depend on the bacteria anyway: stop feeding refined carbohydrate every day and the organisms that thrive on it lose their edge, while the insulin resistance and metaflammation that daily habit sustains lose their fuel.

    What to bring to your next appointment

    • The clock times your cravings arrive and what, exactly, you reach for.
    • Whether sweetened drinks usually come alongside starchy food.
    • What happened the last time you ate well for two straight weeks.
    • A question: can my insulin be measured along with my glucose?
    • A second question: has my resting metabolic rate ever been measured, or only estimated?

    Every study above, with its population and limits, is in the Angry Gut companion deep dive on cravings. The next measuring question, what a gut test can and cannot tell you, is in the methane breath test explained. How sugar feeds inflammation is covered in does sugar cause inflammation, and physicians can read the screening version for practices.

    Frequently asked questions

    Why do I crave sugar at the same time every day?

    A craving that keeps regular hours usually reflects what you have been eating, not who you are. In one controlled study, eight weeks of a daily sweet, fatty snack shifted food preference in normal-weight adults without changing their weight. Recent exposure trains the pattern, and a pattern you can see is one you can measure and change. Read about metabolic rate and energy.

    Can a blood test show sugar addiction?

    No. Food addiction is scored with a questionnaire, and pooled research puts about 20% of people over its threshold. What blood work can show is the metabolic side, such as how glucose and insulin are behaving, which a questionnaire cannot see. Your physician decides what those results mean for you. Learn what a test result can and cannot tell you.

    Can my weight stay normal while my metabolism changes?

    Yes. In the snack study, appetite and brain response to food shifted with no change in body weight, and in the sweetener study insulin sensitivity dropped within about ten days. A scale cannot separate muscle from fat either, which is why bioimpedance body composition measures the compartments directly and reports them to your physician.

    Do gut bacteria cause sugar cravings?

    It has not been shown in people. Mouse studies and one association in women suggest the microbes may take part, and a bacterial fatty acid delivered to the human colon did reduce intake. The proven driver is the food itself, and the gut lining it passes through matters too. See how to test for leaky gut.

    What should I ask my doctor about sugar cravings?

    Ask whether your insulin can be checked alongside glucose, whether your resting metabolic rate was measured or estimated, and whether anything beyond weight has been tracked over time. Bring the times your cravings arrive and what you reach for. Those details turn a willpower conversation into a measurable one. See questions worth asking your doctor.

    What are sugar cravings a sign of?

    Usually a sign of what you have been eating, not a flaw in character. A craving that arrives on a schedule, wants sweet or starchy food and fades after a couple of weeks of better eating is a system answering to its recent diet. It can also travel with metabolic change: in one study, insulin sensitivity dropped within about ten days, a shift no scale can register. Read about insulin resistance and metabolic health.

    How can I stop my body from craving sugar?

    Change the food and give it time. The pattern described in The Angry Gut fades after a couple of weeks of better eating and returns within days of one bad weekend. Stop feeding refined carbohydrate every day and the gut organisms that thrive on it lose their edge, while the insulin resistance and metaflammation that habit sustains lose their fuel. See does sugar cause inflammation.

    Put your cravings in context with real numbers

    Ask about measuring your insulin, resting metabolic rate and autonomic balance, so your physician can see what a scale leaves out.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Hall, K. D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K. Y., Chung, S. T., Costa, E., Courville, A., Darcey, V., Fletcher, L. A., Forde, C. G., Gharib, A. M., Guo, J., Howard, R., Joseph, P. V., McGehee, S., Ouwerkerk, R., Raisinger, K., … Zhou, M. (2019). Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism, 30(1), 67-77.e3. https://doi.org/10.1016/j.cmet.2019.05.008
    • Edwin Thanarajah, S., DiFeliceantonio, A. G., Albus, K., Kuzmanovic, B., Rigoux, L., Iglesias, S., Hanßen, R., Schlamann, M., Cornely, O. A., Brüning, J. C., Tittgemeyer, M., & Small, D. M. (2023). Habitual daily intake of a sweet and fatty snack modulates reward processing in humans. Cell Metabolism, 35(4), 571-584.e6. https://doi.org/10.1016/j.cmet.2023.02.015
    • Dalenberg, J. R., Patel, B. P., Denis, R., Veldhuizen, M. G., Nakamura, Y., Vinke, P. C., Luquet, S., & Small, D. M. (2020). Short-term consumption of sucralose with, but not without, carbohydrate impairs neural and metabolic sensitivity to sugar in humans. Cell Metabolism, 31(3), 493-502.e7. https://doi.org/10.1016/j.cmet.2020.01.014
    • Praxedes, D. R. S., Silva-Júnior, A. E., Macena, M. L., Oliveira, A. D., Cardoso, K. S., Nunes, L. O., Monteiro, M. B., Melo, I. S. V., Gearhardt, A. N., & Bueno, N. B. (2022). Prevalence of food addiction determined by the Yale Food Addiction Scale and associated factors: a systematic review with meta-analysis. European Eating Disorders Review, 30(2), 85-95. https://doi.org/10.1002/erv.2878
    • Byrne, C. S., Chambers, E. S., Alhabeeb, H., Chhina, N., Morrison, D. J., Preston, T., Tedford, C., Fitzpatrick, J., Irani, C., Busza, A., Garcia-Perez, I., Fountana, S., Holmes, E., Goldstone, A. P., & Frost, G. S. (2016). Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. The American Journal of Clinical Nutrition, 104(1), 5-14. https://doi.org/10.3945/ajcn.115.126706
    • Medawar, E., Beyer, F., Thieleking, R., Haange, S.-B., Rolle-Kampczyk, U., Reinicke, M., Chakaroun, R., von Bergen, M., Stumvoll, M., Villringer, A., & Witte, A. V. (2024). Prebiotic diet changes neural correlates of food decision-making in overweight adults: a randomised controlled within-subject cross-over trial. Gut, 73(2), 298-310. https://doi.org/10.1136/gutjnl-2023-330365
    • Dong, T. S., Mayer, E. A., Osadchiy, V., Chang, C., Katzka, W., Lagishetty, V., Gonzalez, K., Kalani, A., Stains, J., Jacobs, J. P., Longo, V. D., & Gupta, A. (2020). A distinct brain-gut-microbiome profile exists for females with obesity and food addiction. Obesity, 28(8), 1477-1486. https://doi.org/10.1002/oby.22870
    • Fletcher, P. C., & Kenny, P. J. (2018). Food addiction: a valid concept?. Neuropsychopharmacology, 43(13), 2506-2513. https://doi.org/10.1038/s41386-018-0203-9

    Related reading

  • Dr. Gurpreet Singh Padda presenting beside the title card Bile Is a Hormone, Not Soap, The Angry Gut, Chapter 23

    What Does Bile Do? It Gives Your Liver Its Orders

    Bile Is a Hormone, Not Soap | The Angry Gut, Chapter 23

    What Does Bile Do? It Gives Your Liver Its Orders

    Bile emulsifies fat, but its main job is signaling: it tells your liver when to stop and your gut hormones when to fire. Remove the reservoir and the timing changes, which is measurable in some ways and not others.

    What does bile do? Almost every answer you have been handed is about grease: bile breaks up fat so you can absorb it. That is true and it is the small half of the job. Bile also carries instructions, and the organ it instructs is your liver. Bile Is a Hormone, Not Soap, the Chapter 23 video for The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, works through the biology. The measuring question is the one worth bringing to an appointment: which parts of this can be put on a number, and which cannot.

    What does bile do? It sends instructions, not just detergent

    Put a primary bile acid onto human ileal tissue, the last stretch of small intestine, at a dose an ordinary meal produces, and the gene for a hormone called FGF19 switches on 350-fold. In a living person that signal runs on a clock: it climbs after eating, peaks 90 to 120 minutes behind the meal-driven rise in bile acids, and tells the liver to ease off. Fast, and the rhythm disappears.

    Notice the direction of the conversation. The gut measures what arrived and tells the organ upstream how much to send next. Your gut is the first brain here, and the liver is taking orders from it, not the other way around. Nothing about that arrangement fits the schoolroom picture of bile as a fluid pushed downhill to dissolve a fried egg.

    Why this reaches your blood sugar and your appetite

    The same molecule hits a second receptor on the hormone cells of the bowel. When a bile salt was placed against those cells in ten people with obesity and type 2 diabetes, blood glucose fell by up to 3.8 mmol/l and the food eaten at the next unrestricted meal fell by up to 47%. Two days of an oral bile acid in healthy women raised brown fat activity and whole-body energy expenditure.

    The cleanest proof that this is signaling rather than digestion is a binding resin that stays in the lumen. Nothing about it enters the bloodstream, so it never reaches the pancreas. Pooled across 17 trials, in a combined 2,950 patients, it still pulled down HbA1c, the average blood sugar reading, by half a percentage point, 0.55% to be precise. A substance your body cannot take up, acting on a receptor in your intestine, moved your blood sugar.

    There is a behavioral layer under all of this, and it was prescribed. For decades anyone with a touchy gallbladder was told to keep fat low and keep the organ quiet. Fat arriving in the duodenum is the signal that empties a gallbladder, so a quiet one is a full one, and bile that sits still concentrates. The advice produced the stasis that the surgery later collected.

    What changes after gallbladder removal?

    The gallbladder is not a bag. Its lining carries the message for that same hormone at roughly 250-fold the level of the nearby small intestine. Remove it and bile acid production rises at least two-fold while the daily rhythm of the hormone flattens out.

    The symptom that follows is a timing problem rather than a hormone shortage, and that distinction has been tested directly: when investigators looked for a link between the hormone content of the removed gallbladder and anyone’s bowel habit, they did not find one. What changes is delivery. A gallbladder saves bile between meals and releases it as a bolus when fat arrives; without one, bile trickles all day into a bowel built to receive it in pulses, more of it passes downstream, and the colon reads bile acids as an order to secrete water. That is the loose, urgent stool after a fatty meal.

    Then the number that should embarrass the system. Among 9,439 people who had the operation, 202, or 2.1%, were ever investigated for diarrhea afterward. Of those who were tested, 62.8% had bile acid diarrhea, which is named, testable and treatable. Those figures come from an audit of patients a clinician already suspected, so they describe how rarely the question gets asked rather than how common the condition is.

    The bile tests are real, and they are not Measura tests

    Measura [Cardiometabolic and Autonomic Health Analysis] is built around blood work, body composition and resting metabolism, plus vascular, autonomic, small-fiber, balance and cognitive measurement. Bile acid testing is not in that library, and neither is gallbladder imaging, the nuclear scan that reports an ejection fraction, or breath testing. Those belong to your physician and a gastroenterologist, and the retention scan used in Europe is not licensed in the United States, which is why an American conversation often ends up being about a supervised trial of a binder with a defined endpoint instead. Any of that is a prescribing decision for your own doctor, not something to start or stop on your own.

    What can be measured in the same person

    What Measura can do is measure the terrain that grew the stone in the first place and the consequences you are living with now. Bile acids sit inside energy regulation, so the metabolic picture is not a side issue here.

    • Laboratory panels document fuel handling, inflammation and liver and kidney status in blood, which is where the stone-growing terrain shows up.
    • Bioimpedance body composition separates muscle from fat, so months of restricted eating and avoided meals can be seen rather than guessed at. Body composition, not BMI explains why that distinction matters.
    • Indirect calorimetry measures what you burn at rest instead of estimating it, which matters when weight has drifted since the operation.

    None of those results is a diagnosis. They go to your physician, alongside the bowel history, so the decisions get made with numbers in the room.

    What to ask for at your next visit

    • When the stool change began: before the operation, weeks after it, or months after it.
    • Whether your original pain was the classic biliary pattern or an atypical one.
    • If an ejection fraction was measured, what it was and which infusion protocol produced it.
    • Whether testing for bile acid diarrhea is available where you live, and if not, what a supervised trial with a stop date would look like.
    • Whether your metabolic picture has ever been measured, not just your gallbladder. Insulin resistance and metabolic health covers that ground.

    Every study behind these numbers, with its limits stated, is in the book companion for The Angry Gut. The version written for physicians is the screening view of post-surgical complications.

    Frequently asked questions

    Can Measura test my bile acids or my gallbladder?

    No. Bile acid testing, gallbladder ultrasound and the nuclear scan that produces an ejection fraction are different tests, arranged by your physician or a gastroenterologist. What can be measured here is the metabolic, vascular, autonomic and body-composition picture in the same person, which is where the terrain behind gallstones shows itself. See what Measura actually measures.

    Why would loose stools start months after gallbladder surgery?

    Because the change is in timing rather than in an organ failing. Without a reservoir, bile arrives steadily instead of in a burst after fat, more of it reaches the colon, and the colon answers bile acids by secreting water. The interval before symptoms appear varies, which is one reason the connection gets missed. How long that gap runs before anyone tests is in the screening view of post-surgical complications.

    Does bile really affect blood sugar and weight?

    The signaling does. In ten people with obesity and type 2 diabetes a bile salt lowered glucose and cut how much they ate at the following meal, and a binder confined to the bowel moved HbA1c by 0.55% in a pooled analysis covering 2,950 patients across 17 trials. That is why the metabolic picture belongs in this conversation. Read about metabolic rate and energy.

    Is an irritable bowel label ever wrong after this operation?

    It can be incomplete. In one audit only 2.1% of 9,439 people who had the operation were ever investigated for diarrhea, and most of those tested turned out to have bile acid diarrhea. A label that closes the file is different from a label that opens a test, and the questions you bring matter. See questions worth asking your doctor.

    What should I bring to the visit?

    A dated timeline of the stool change, the operation date, your original pain pattern, any ejection fraction result, your full medication list and a note of which foods trigger symptoms. Preparation changes what a single appointment can settle, and it keeps the conversation on measurement rather than on labels. Read how to prepare.

    What is the main function of bile?

    Bile emulsifies fat, but its main job is signaling. After a meal, bile acids reaching the last stretch of small intestine switch on a hormone called FGF19, which peaks 90 to 120 minutes behind the meal-driven rise in bile acids and tells the liver to ease off. The same molecules act on the hormone cells of the bowel, which is how bile reaches your blood sugar and your appetite.

    Where is bile stored?

    In the gallbladder. It saves bile between meals and releases it as a burst when fat arrives in the duodenum, the first part of the small intestine. Without a gallbladder, bile trickles into the bowel all day instead of arriving in pulses, more of it passes downstream, and the colon reads bile acids as an order to secrete water. That is the loose, urgent stool after a fatty meal.

    Measure the terrain, not just the organ

    Ask about laboratory, body composition and resting metabolism testing so your physician can see the metabolic picture behind your gallbladder history in numbers.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Zhang, J. H., Nolan, J. D., Kennie, S. L., Johnston, I. M., Dew, T., Dixon, P. H., Williamson, C., & Walters, J. R. F. (2013). Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. American Journal of Physiology. Gastrointestinal and Liver Physiology, 304(10), G940-G948. https://doi.org/10.1152/ajpgi.00398.2012
    • Lundåsen, T., Gälman, C., Angelin, B., & Rudling, M. (2006). Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. Journal of Internal Medicine, 260(6), 530-536. https://doi.org/10.1111/j.1365-2796.2006.01731.x
    • Adrian, T. E., Gariballa, S., Parekh, K. A., Thomas, S. A., Saadi, H., Al Kaabi, J., Nagelkerke, N., Gedulin, B., & Young, A. A. (2012). Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia, 55(9), 2343-2347. https://doi.org/10.1007/s00125-012-2593-2
    • Hansen, M., Sonne, D. P., Mikkelsen, K. H., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2017). Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials. Journal of Diabetes and Its Complications, 31(5), 918-927. https://doi.org/10.1016/j.jdiacomp.2017.01.011
    • Barrera, F., Azócar, L., Molina, H., Schalper, K. A., Ocares, M., Liberona, J., Villarroel, L., Pimentel, F., Pérez-Ayuso, R. M., Nervi, F., Groen, A. K., & Miquel, J. F. (2015). Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19. Annals of Hepatology, 14(5), 710-721. https://pubmed.ncbi.nlm.nih.gov/26256900/
    • Farrugia, A., Attard, J. A., Hanmer, S., Bullock, S., McKay, S., Al-Azzawi, M., Ali, R., Bond-Smith, G., Colleypriest, B., Dyer, S., Masterman, B., Okocha, M., Osborne, A., Patel, R., Sallam, M., Selveraj, E., Shalaby, S., Sun, W., Todd, F., … Arasaradnam, R. P. (2021). Rates of bile acid diarrhoea after cholecystectomy: A multicentre audit. World Journal of Surgery, 45(8), 2447-2453. https://doi.org/10.1007/s00268-021-06147-8
    • Wedlake, L., A’Hern, R., Russell, D., Thomas, K., Walters, J. R. F., & Andreyev, H. J. N. (2009). Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 30(7), 707-717. https://doi.org/10.1111/j.1365-2036.2009.04081.x

    Related reading

  • Dr. Gurpreet Singh Padda presenting beside the title card Six Meals a Day Is a Business Model, The Angry Gut, Chapter 19

    Visceral Fat vs Subcutaneous Fat: What Testing Can Show

    Six Meals a Day Is a Business Model | The Angry Gut, Chapter 19

    Visceral Fat vs Subcutaneous Fat: What Testing Can Show

    Subcutaneous fat sits under the skin; visceral fat packs in around the organs. Only imaging can draw the line between the two. Bioimpedance body composition estimates muscle, fat and water and tracks your own numbers over time, which a scale cannot do.

    Weight is the endpoint the fasting trials used, and it is the wrong one. The deep fat around your organs and the fat under your skin move independently, and only one of them behaves like an inflamed organ.

    The visceral fat vs subcutaneous fat distinction is the one your bathroom scale cannot make, and it is the distinction that decides whether a change in how you eat did anything worth doing. Subcutaneous fat sits under the skin. Visceral fat packs in around the organs, and it is the compartment that behaves like an inflamed organ in its own right. A scale adds them together with muscle, water and last night’s dinner, then reports one number. The video Six Meals a Day Is a Business Model, from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, makes the motility argument. This is the measuring one.

    Visceral fat vs subcutaneous fat: which one comes off first?

    Look at what happens when somebody images the compartments instead of weighing the person. Across a seven-day water-only fast in 12 volunteers, fat under the skin fell significantly while the visceral depot did not budge. When the depth of the fast became the randomized variable across 76 adults, alternate-day fasting reduced visceral fat mass and an eight-hour eating window did not, with energy intake down 34 percent in the deeper arm against 15 percent in the shallow one. The deep compartment answers to depth. A shallow schedule never reaches it, and a scale cannot tell you which one you got.

    There is a second reason weight misleads. In a supervised ten-day fast, most of what came off was lean tissue, not fat. After the seven-day fast, lean mass moved from a loss of 3.6 kilograms to a loss of 0.69 within three days of eating again, while the fat loss held. So the number on the scale during a long gap is mostly reporting water and muscle, and it gives back much of what it took as soon as food returns.

    What does a bioimpedance body composition test measure?

    Measura [Cardiometabolic and Autonomic Health Analysis] measures bioimpedance body composition, which estimates the compartments — muscle, fat and water — by passing a small current through the body. Be clear about what that is and is not. It is an estimate of compartments, not a picture of them. It is not imaging, and it cannot draw the line between visceral and subcutaneous fat the way a scan can. Imaging is a different test, ordered elsewhere by your physician. What bioimpedance does well is track your own muscle and fat over time, which is the thing a scale hides and the thing most likely to be moving in the wrong direction while the weight stays flat.

    How do you measure your metabolic rate?

    Indirect calorimetry measures your resting metabolic rate from the oxygen you use and the carbon dioxide you make, rather than predicting it from an equation built on other people. If you have been told your metabolism is broken, or that skipping meals broke it, that is the measurement that settles the argument in your own body. Laboratory panels then put numbers on the metabolic and inflammatory terrain, the metaflammation that keeps insulin high and fat locked in storage. Results go to your physician; Measura measures and does not treat.

    Why start there rather than with a diet? Because being metabolically healthy is now unusual, and the terrain is what decides whether fat can leave storage at all. Fewer than 12.2 percent of US adults met the standard on NHANES 2009 to 2016, and fewer than 7 percent under the stricter post-2021 criteria. Among the patients who come through our own doors it is under 3 percent overall and under 1 percent of those living with chronic pain — practice-reported figures from our own population, not trial outcomes, and individual results vary. The first brain sits inside that terrain, which is why the gut and the metabolism are one conversation rather than two.

    Is eating six small meals a day better than three?

    The strongest version of the grazing argument is that frequent small meals keep the furnace stoked. It was tested in a metabolic chamber, a sealed room that measures every breath: three meals a day against six produced the same 24-hour energy expenditure and the same fat oxidation, 82 against 80 grams a day. Hunger was the one thing that climbed on the six-meal days. Among adults with type 2 diabetes eating identical calories and macronutrients, two meals a day beat six, with 3.7 kilograms lost against 2.3 and a greater fall in liver fat. Grazing advice did not arrive from nowhere either; an industry built on between-meal eating needs mouths that rarely close. Name the incentive, not a villain.

    So the useful endpoints are the compartments and the numbers, not the schedule. Two people can eat the same way for three months and have opposite results in muscle, fat and insulin, and only one of them will find that out.

    Before you change anything

    Two cautions, and they are not decoration. If you take any medication that lowers blood sugar or blood pressure, do not start fasting or lengthen your overnight gap without talking to the physician who prescribes it; a fast changes what those drugs do to you, and in one study the need for blood pressure medication fell months afterward. And a fast is a dose. Among 2,762 young people, 47.7 percent of the women reported intermittent fasting within the year, and the practice tracked with eating-disorder psychopathology. If food has ever been a battleground for you, that history belongs in the conversation before any schedule does.

    Ask for the measurements first: body composition, a measured resting metabolic rate, and laboratory markers of insulin and inflammation. Then repeat them, because a single reading is a dot and you need a line. Background on the numbers is in metabolic rate and energy, and every study named here with its full figures and limits sits in the companion deep dive for The Angry Gut. The testing side of the previous chapter is what a gut microbiome test cannot measure, and clinicians will want the version written for physicians. The same visceral depot sits behind a share of cancer risk, discussed in whether obesity causes cancer.

    Frequently asked questions

    Which is worse, visceral fat or subcutaneous fat?

    Visceral fat is the compartment tied most closely to metabolic and inflammatory trouble, which is why it is the endpoint worth following. The practical problem is that the two move independently: a seven-day fast lowered the fat under the skin while the deep depot held still. A weight change tells you nothing about which one moved. See why body composition is not weight.

    Can a body composition scan see my visceral fat?

    Bioimpedance estimates your fat, muscle and water compartments; it does not photograph them, and it is not imaging. It cannot separate the deep abdominal depot from the fat under your skin the way a scan can, and that scan is a different test ordered elsewhere. What bioimpedance does reliably is follow your own muscle and fat over months. Read why body composition beats BMI.

    Is intermittent fasting safe if I take medication for diabetes?

    Not a question to settle on your own. Medications that lower blood glucose or blood pressure behave differently when meals move, and that is a conversation with the prescriber before the schedule changes, not after. Nothing here is advice to start, stop or adjust a drug. Measurement is the part you can ask for safely today. Read about insulin resistance and metabolic health.

    Does eating six small meals a day speed up metabolism?

    It has never been shown to. Chamber measurements found identical daily energy expenditure and identical fat oxidation at three meals and at six, and in type 2 diabetes two meals a day outperformed six at matched calories. The measurable difference was hunger. If you want to know your own rate rather than guess it, measure it. Compare measured and estimated metabolic rate.

    How often should these numbers be repeated?

    Often enough to make a line rather than a dot, and that interval depends on what you and your physician are trying to move. Body composition and laboratory markers change on a scale of months, not days, so weekly measurement mostly records noise. Agree on the repeat interval when the first set is ordered. See how often testing is repeated.

    How can I tell if my belly fat is visceral or subcutaneous?

    Not with a scale. Only imaging draws the line between the fat packed around your organs and the fat under your skin, and that scan is a different test your physician orders elsewhere. Bioimpedance estimates your total fat, muscle and water and follows them over time, which tells you whether the change you made moved fat or muscle.

    What gets rid of visceral fat?

    In the trials on this page, depth mattered more than the schedule. Across 76 adults, alternate-day fasting reduced visceral fat mass and an eight-hour eating window did not. A fast is a dose, so talk first with the physician who prescribes any blood sugar or blood pressure medication, and measure body composition before and after rather than trusting the scale.

    Follow the compartments, not the scale

    Ask about body composition, measured resting metabolic rate and metabolic laboratory testing so you and your physician can see which compartment is actually moving.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Pietzner, M., Uluvar, B., Kolnes, K. J., Jeppesen, P. B., Frivold, S. V., Skattebo, Ø., Johansen, E. I., Skålhegg, B. S., Wojtaszewski, J. F. P., Kolnes, A. J., Yeo, G. S. H., O’Rahilly, S., Jensen, J., & Langenberg, C. (2024). Systemic proteome adaptions to 7-day complete caloric restriction in humans. Nature Metabolism, 6(4), 764-777. https://doi.org/10.1038/s42255-024-01008-9
    • Derron, N., Güntner, A. T., Weber, I. C., Braun, J., Koska, İ. Ö., Othman, A., Mönch, L., von Eckardstein, A., Puhan, M. A., Beuschlein, F., Hochuli, M., Zamboni, N., Guggenberger, R., & Gerber, P. A. (2025). Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity – A randomized clinical trial. Clinical Nutrition, 53, 212-221. https://doi.org/10.1016/j.clnu.2025.08.033
    • Ohkawara, K., Cornier, M.-A., Kohrt, W. M., & Melanson, E. L. (2013). Effects of increased meal frequency on fat oxidation and perceived hunger. Obesity, 21(2), 336-343. https://doi.org/10.1002/oby.20032
    • Kahleova, H., Belinova, L., Malinska, H., Oliyarnyk, O., Trnovska, J., Skop, V., Kazdova, L., Dezortova, M., Hajek, M., Tura, A., Hill, M., & Pelikanova, T. (2014). Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: A randomised crossover study. Diabetologia, 57(8), 1552-1560. https://doi.org/10.1007/s00125-014-3253-5
    • Laurens, C., Grundler, F., Damiot, A., Chery, I., Le Maho, A.-L., Zahariev, A., Le Maho, Y., Bergouignan, A., Gauquelin-Koch, G., Simon, C., Blanc, S., & Wilhelmi de Toledo, F. (2021). Is muscle and protein loss relevant in long-term fasting in healthy men? A prospective trial on physiological adaptations. Journal of Cachexia, Sarcopenia and Muscle, 12(6), 1690-1703. https://doi.org/10.1002/jcsm.12766
    • Ganson, K. T., Cuccolo, K., Hallward, L., & Nagata, J. M. (2022). Intermittent fasting: Describing engagement and associations with eating disorder behaviors and psychopathology among Canadian adolescents and young adults. Eating Behaviors, 47, 101681. https://doi.org/10.1016/j.eatbeh.2022.101681
    • Maifeld, A., Bartolomaeus, H., Löber, U., Avery, E. G., Steckhan, N., Markó, L., Wilck, N., Hamad, I., Šušnjar, U., Mähler, A., Hohmann, C., Chen, C.-Y., Cramer, H., Dobos, G., Lesker, T. R., Strowig, T., Dechend, R., Bzdok, D., Kleinewietfeld, M., … Forslund, S. K. (2021). Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients. Nature Communications, 12(1), 1970. https://doi.org/10.1038/s41467-021-22097-0

    Related reading

  • Dr. Gurpreet Singh Padda presenting beside the title card Your Immune System Is Not Confused, The Angry Gut, Chapter 16

    How to Measure Visceral Fat When the Scale Says You’re Fine

    Your Immune System Is Not Confused | The Angry Gut, Chapter 16

    How to Measure Visceral Fat When the Scale Says You’re Fine

    Visceral fat is imaged directly on CT or MRI. Bioimpedance body composition separates fat mass from lean mass, and blood work such as fasting glucose, insulin, lipids and liver enzymes shows what the depot is doing downstream; weight and body mass index cannot locate it.

    Your weight and body mass index cannot show where your fat sits or whether it has turned into immune tissue. Location predicts the harm, and location has to be measured.

    Knowing how to measure visceral fat matters more than knowing what you weigh, because the fat packed around your intestines and liver behaves like an immune organ, and it can be inflamed in a person whose scale reading looks ordinary. In the video Your Immune System Is Not Confused, from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, that fat is one part of a larger argument about Crohn’s disease and a chronic immune load. Here the question is narrower and practical: what would show that load in you, what a routine visit checks, and what it leaves out.

    Why doesn’t a normal weight rule out visceral fat?

    For years I told people with borderline blood sugar that their numbers were not too bad, and a normal weight made that sentence easier to say. It was the wrong reassurance. Weight is a total. It says nothing about where fat is stored or what the cells inside it are doing.

    In the fat of lean mice and lean humans, macrophages, the immune system’s cleanup cells, make up under 10% of the cells. In the most obese mice they pass 50%. In people, the better predictor of that crowding was not body mass index but the size of the individual fat cells, at r² = 0.86 against 0.43 for body mass index. Swollen fat cells are the ones that struggle first, and resident immune cells arrive to help. That help becomes a steady inflammatory signal: more than 90% of what fat tissue releases, apart from the hormones adiponectin and leptin, comes from the immune and support cells living in it, not from the fat cells.

    What makes visceral fat dangerous?

    In people with obesity, the omental fat that hangs inside the abdomen carried twice as many macrophages as fat under the skin, and that omental burden tracked fasting glucose, insulin sensitivity and liver injury. This fat drains through the portal vein to the liver. In severely obese adults sampled during bariatric surgery, portal blood carried about 50% more interleukin-6, an inflammatory messenger, than arterial blood. Your liver gets the first and strongest dose.

    The pattern holds when weight is taken out of the picture. In omental biopsies from women having endometrial cancer surgery, dying fat cells surrounded by macrophages were found in 48% of samples, and they went with diabetes rather than body mass index. In an imaging cohort of 3,086 adults with a mean age of 50.2, more visceral fat meant higher risk of heart and blood vessel disease (hazard ratio 1.44) and of cancer (1.43), and that held even with body mass index accounted for. South Asians carry more visceral fat and less thigh muscle for their body size. A person of normal weight with disproportionate visceral fat is not lean, whatever the chart says.

    None of this is a character flaw. Agricultural subsidies make refined carbohydrate and industrial seed oil the cheapest food on the shelf, your first brain, the gut, absorbs the surplus, and the overflow is stored on the road leading out of it, where metaflammation starts.

    What does visceral fat have to do with Crohn’s disease?

    In Crohn’s disease, fat can wrap the inflamed intestine. Researchers cultured live bacteria from the mesenteric fat of 9 of 11 people with Crohn’s disease, and also from 4 of 4 healthy controls, so bacteria in that fat are expected; the fat is placed to meet them. What differed in Crohn’s was which organisms arrived.

    Be clear about the limits. Measura [Cardiometabolic and Autonomic Health Analysis] does not diagnose Crohn’s disease and does not monitor it. It does not replace calprotectin, endoscopy or your gastroenterologist’s plan, which are done elsewhere. If you take a biologic, nothing here is a reason to stop it. Loss of response to anti-TNF drugs runs at about 20.9% per patient-year, so the question is what gets measured and repaired while the drug holds. Measura can add the metabolic picture under the disease, the one nobody on the immune side is charting.

    How do you measure visceral fat, and what does each method show?

    • Weight and body mass index. A total and a ratio. They cannot locate fat or see muscle, and they are where most visits stop.
    • CT or MRI. Imaging sees the visceral compartment directly and was the method behind the cohort above. It is done elsewhere, usually for another reason. If you have had a scan, ask whether the report described visceral fat.
    • Body composition. Bioimpedance body composition sends a small, painless electrical signal through the body to estimate fat mass and lean mass separately, so muscle and fat stop hiding inside one number. It is an estimate rather than an image, and its strength is the pattern and the trend across repeat visits.
    • Blood work. Laboratory panels show what the depot is doing downstream: fasting glucose and insulin, lipids, liver enzymes and inflammatory markers, the same kinds of values the omental burden tracked in surgical patients.

    The non-obvious point is that quieting the signal does not change the depot. In 56 people with metabolic syndrome, the drug etanercept cut C-reactive protein sharply over four weeks, yet body composition and insulin sensitivity did not budge. A lower inflammation number is not a smaller visceral compartment, which is why composition and metabolic labs are worth tracking together. Unmeasured is unmanaged.

    Does visceral fat travel with fat around the heart?

    Often, and the fat around the heart may matter more than the fat in the belly. An international position statement on visceral and ectopic fat treats visceral fat measured by CT or MRI as an independent risk marker for cardiovascular and metabolic disease and death, and places fat stored in the liver and on the surface of the heart beside it as emerging risk factors. The heart’s own fat layer is the one that sits closest to the damage: in paired samples from 42 bypass patients, fat taken from the surface of the heart made more of the inflammatory messengers interleukin-1 beta, interleukin-6, MCP-1 and TNF-alpha than fat from under the skin, regardless of diabetes, BMI or statin use.

    No scale or tape measure sees the fat on the heart, and Measura does not image it. What a body composition test and an insulin level do show is whether you live in the metabolic setting where those depots grow. How fat around the heart injures it explains the outside-in mechanism, and obesity and heart disease: fat mass and sick fat puts both depots in the larger picture.

    What should you ask your doctor about visceral fat?

    • Ask which fat has ever been measured, or whether weight is standing in for it. The difference is laid out in body composition, not BMI.
    • Ask for fasting insulin alongside glucose. Glucose can stay normal while insulin works harder to hold it there; see insulin resistance and metabolic health.
    • If you are South Asian, or diabetes runs in your family, say so at the start of the visit.
    • If you have Crohn’s disease, ask who is responsible for your metabolic terrain while the biologic holds the bowel still.
    • Ask whether a repeat body composition test can show a trend rather than a single snapshot.

    Results go to your physician, who decides what they mean for your care. The book companion, the deep dive on the immune matrix, lists every study above with its limits. Sleep and schedule sit on top of this same terrain, covered in night shift health risks you can measure. In MRI data from more than thirty thousand adults, the same visceral depot tracked how many places hurt, covered in whether belly fat can cause chronic pain.

    Frequently asked questions

    Can you have too much visceral fat at a normal weight?

    Yes. In omental biopsies, inflamed fat went with diabetes rather than body mass index, and in an imaging cohort visceral fat predicted heart disease and cancer after adjusting for body mass index. South Asians tend to carry more of this depot for their size. A normal scale reading is not a measurement of where fat is stored. See why body composition is not the same as weight.

    Does bioimpedance measure visceral fat directly?

    No. Bioimpedance estimates fat mass and lean mass from how a small electrical signal moves through the body. CT and MRI image the visceral compartment directly but are done elsewhere. Bioimpedance is most useful for separating muscle from fat and for following the same person over time, alongside metabolic blood work. See what a test result can and cannot tell you.

    Can Measura tell me whether my Crohn’s disease is flaring?

    No. Measura does not diagnose or monitor Crohn’s disease. Flares are assessed by your gastroenterologist with tests done elsewhere. Measura measures the metabolic side, such as body composition and laboratory markers of insulin resistance and inflammation, and sends results to your physician so the terrain under the disease is charted too. See who should be tested.

    Why is fat inside the abdomen worse than fat under the skin?

    Location changes who hears the signal. Omental fat carried twice the macrophages of fat under the skin in people with obesity, and it drains to the liver, where portal blood held about half again as much interleukin-6 as arterial blood. That burden tracked blood sugar, insulin sensitivity and liver injury. Learn what laboratory panels include.

    Should I stop my biologic if my visceral fat is high?

    No. Never stop or change a medication because of a measurement without your physician. A biologic holds an inflamed bowel still, and stopping it to test a theory risks the bowel. Visceral fat is a reason to measure and address the terrain alongside the drug, not instead of it. See questions worth asking your doctor.

    Is there a way to measure visceral fat at home?

    Not with a bathroom scale. Weight is a total and body mass index is a ratio, so neither can show where fat sits or separate it from muscle. CT or MRI sees visceral fat directly. Bioimpedance body composition estimates fat mass and lean mass separately, and blood work shows what the fat is doing downstream. If you have ever had a scan, ask whether the report described visceral fat.

    What are signs of high visceral fat?

    You may not see it: visceral fat can be inflamed in a person whose scale reading looks ordinary. The signal shows up in blood work, including fasting glucose and insulin, lipids, liver enzymes and inflammatory markers. In surgical patients, the fat inside the abdomen tracked blood sugar, insulin sensitivity and liver injury. If you are South Asian or diabetes runs in your family, measure rather than assume.

    What are the worst foods for visceral fat?

    Refined carbohydrate and industrial seed oil. Agricultural subsidies make them the cheapest food on the shelf. Your gut absorbs the surplus, and the overflow is stored in the fat along the road leading out of it, the visceral depot that drains to the liver. That is where metaflammation starts. None of this is a character flaw; it is what a cheap food supply delivers.

    Find out where your fat is, not just how much

    Ask about body composition and metabolic laboratory testing so your physician has measurements of the terrain, not a weight standing in for it.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003). Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation, 112(12), 1796-1808. https://doi.org/10.1172/JCI19246
    • Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Bar Hen, A., Bedossa, P., Guerre-Millo, M., & Clement, K. (2006). Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes, 55(6), 1554-1561. https://doi.org/10.2337/db06-0133
    • Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007). Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56(4), 1010-1013. https://doi.org/10.2337/db06-1656
    • van den Bosch, A. A. S., Kooreman, L., van de Weijer, T., Romano, A., Brecheisen, R., Jin, X., Delvoux, B., Kruitwagen, R. F. P. M., Pijnenborg, J. M. A., & Werner, H. M. J. (2026). Visceral adipose tissue inflammation in endometrial cancer. Cancer Treatment and Research Communications, 48, 101273. https://doi.org/10.1016/j.ctarc.2026.101273
    • Britton, K. A., Massaro, J. M., Murabito, J. M., Kreger, B. E., Hoffmann, U., & Fox, C. S. (2013). Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. Journal of the American College of Cardiology, 62(10), 921-925. https://doi.org/10.1016/j.jacc.2013.06.027
    • Eastwood, S. V., Tillin, T., Wright, A., Mayet, J., Godsland, I., Forouhi, N. G., Whincup, P., Hughes, A. D., & Chaturvedi, N. (2014). Thigh fat and muscle each contribute to excess cardiometabolic risk in South Asians, independent of visceral adipose tissue. Obesity (Silver Spring, Md.), 22(9), 2071-2079. https://doi.org/10.1002/oby.20796
    • Ha, C. W. Y., Martin, A., Sepich-Poore, G. D., Shi, B., Wang, Y., Gouin, K., Humphrey, G., Sanders, K., Ratnayake, Y., Chan, K. S. L., Hendrick, G., Caldera, J. R., Arias, C., Moskowitz, J. E., Ho Sui, S. J., Yang, S., Underhill, D., Brady, M. J., Knott, S., … Devkota, S. (2020). Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans. Cell, 183(3), 666-683.e17. https://doi.org/10.1016/j.cell.2020.09.009
    • Qiu, Y., Chen, B.-L., Mao, R., Zhang, S.-H., He, Y., Zeng, Z.-R., Ben-Horin, S., & Chen, M.-H. (2017). Systematic review with meta-analysis: Loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease. Journal of Gastroenterology, 52(5), 535-554. https://doi.org/10.1007/s00535-017-1324-3
    • Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., & Bahouth, S. W. (2004). Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 145(5), 2273-2282. https://doi.org/10.1210/en.2003-1336
    • Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006). Effects of etanercept in patients with the metabolic syndrome. Archives of Internal Medicine, 166(8), 902-908. https://doi.org/10.1001/archinte.166.8.902
    • Neeland, I. J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., et al. (2019). Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & Endocrinology, 7(9), 715-725. https://doi.org/10.1016/S2213-8587(19)30084-1 (PMID 31301983)
    • Mazurek, T., Zhang, L., Zalewski, A., Mannion, J. D., Diehl, J. T., Arafat, H., et al. (2003). Human epicardial adipose tissue is a source of inflammatory mediators. Circulation, 108(20), 2460-2466. https://doi.org/10.1161/01.CIR.0000099542.57313.C5 (PMID 14581396)

    Related reading

  • Dr. Gurpreet Singh Padda beside the chapter title card reading Your Microbes Read the Label, Not the Macros, The Angry Gut, Chapter 15

    Emulsifiers in Food: What No Test Can Measure About You

    Your Microbes Read the Label, Not the Macros | The Angry Gut, Chapter 15

    Emulsifiers in Food: What No Test Can Measure About You

    Emulsifiers in food reach you as a mixture of lecithins, mono- and diglycerides, carrageenan and phosphates, eaten several times a day for years, and no test in ordinary practice measures how much of it you have eaten.

    Your macros can be fine while your microbes only ever see the ingredient list. Nothing sold as a test can measure that exposure, which makes the next question what can be measured.

    Emulsifiers in food are the second diet most people are eating without knowing it. The first diet is the one on the nutrition label, where the calories and the protein look reasonable. The second is the ingredient list underneath, and your bacteria are the ones reading it.

    The video Your Microbes Read the Label, Not the Macros follows a woman of forty-one whose week of food photographs would pass any dietitian’s review, until the labels were read aloud. It belongs to The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service, and no test in its library measures what additives you have eaten, because no such measurement exists in ordinary practice.

    Emulsifiers in food are a mixture, not a chemical

    Among 106,489 French adults, forty-eight additives were eaten by more than 10% of people surveyed. Lecithins reached 86.6% of consumers, mono- and diglycerides of fatty acids 78.1%, carrageenan 77.5%, and the phosphate group 70.1%. People did not meet these compounds one at a time either; they arrived in recognizable clusters, several times a day, for years.

    That matters for anyone hunting a single culprit. The compound most of the laboratory work studies is carboxymethylcellulose, sold on labels as cellulose gum. It is not the exposure. The exposure is the whole cluster, eaten by a body nobody asked.

    The wall these compounds meet is thinner than advertised

    Before anything can be said to strip a gut lining, someone has to measure the lining. The figures in wide circulation, around 830 microns of colonic mucus gel with roughly 116 microns firmly attached, were measured in rats. Human sigmoid biopsies gave a mean inner mucus thickness of 19.4 microns, with a standard deviation of 9.9 and a range from 6.2 to 45.6.

    Two honest caveats come with those human numbers. The loose outer layer was missing from every biopsy, because bowel preparation washes it away in 96% of prepared subjects, and in paired animal samples the choice of preservative alone changed the measured thickness. Every human mucus number came out of a specimen jar. The wall is real; it is also a fraction of the number people quote, and it is the surface your first brain keeps between itself and everything you swallow, while the second brain in your skull never meets any of it.

    How do emulsifiers affect gut bacteria?

    Dr. Padda explained this the easy way for years: emulsifiers are detergents, dish soap on the lining. He now says that version was half right and it was the wrong half. In mice raised with no gut bacteria at all, neither compound thinned the mucus, and beads the size of bacteria stayed as far from the tissue as they had started. In animals carrying only a small defined set of bacteria, nothing happened either.

    Grow a human microbial community outside a body, add cellulose gum, and its inflammatory potential rises while the roster of species present does not significantly change. Read that twice, because it decides what testing can see. The population held still and the behavior changed, so a stool census would have reported that nothing happened. When twenty common emulsifiers were screened this way, the starkest damage came from the carrageenans and the gums, two of which were on that patient’s labels.

    What happened when healthy people ate an emulsifier?

    Only one randomized trial has fed a purified emulsifier to healthy humans. Its sixteen adults spent eleven days on a diet stripped of other emulsifiers, with 15 g of cellulose gum a day added for seven of them. The distance between bacteria and the intestinal wall, the measure the trial was built to detect, did not change. Encroachment turned up in 2 of 7 treated volunteers and 0 of 9 controls. What did move was the composition of the microbiota, the chemistry of the stool, and abdominal discomfort after meals.

    That is a modest result, and the reason matters more than the verdict. One additive, on a background diet scrubbed of the rest, in metabolically healthy volunteers, for eleven days. Trials remove the complicated patient to get a clean answer, and the complicated patient is the one reading labels in the kitchen.

    What can a test measure instead of emulsifiers?

    There is a real measurement in this literature, and it is about the body rather than the shelf. In 42 people having colonoscopy, people with type 2 diabetes had their bacteria sitting almost 3-fold closer to the nearest lining cell. It tracked hemoglobin A1c at an r-squared of 0.51 and fasting glucose at 0.46, but body mass index only at 0.16. Obesity by itself did nothing, and removing the subjects with diabetes erased the difference entirely.

    The wall tracked blood sugar, not waist size. That is why the useful tests here measure metabolic state:

    • Laboratory panels put current numbers on blood sugar, lipids and inflammatory markers, which is where metaflammation stops being a word and becomes a result.
    • Bioimpedance body composition separates fat from muscle, which matters because body mass index was the weakest of the three measures above.

    Neither test measures additives, mucus or bacteria, and neither diagnoses a gut disease. They describe the state your body is in while it meets that mixture daily, and the findings go to your physician. Good metabolic health is rare: under 12.2% of adults on NHANES 2009-2016, and under 7% on the tighter post-2021 criteria.

    How can you cut back on emulsifiers?

    The prescription is shorter than the science. Fewer items with ingredient lists, more items with none. People can actually do this, and somebody measured it: in stable Crohn’s disease, a low-emulsifier diet cut the frequency of additive-carrying foods by 94.6%.

    • Read your own labels for a week before changing anything, and count how many distinct additives you meet in a day.
    • Remember that engineered food does two things at once. It adds the compounds and removes the fermentable fiber, and in mice deprived of fiber the mucus layer thinned five- to six-fold while the bacteria turned on the wall itself for food.
    • Expect the calories to argue back. Twenty adults fed matched macronutrients ate 508 kcal a day more on the ultra-processed menu and gained weight on it, while losing weight on the unprocessed one.
    • Do not stop a prescribed medication or a therapeutic diet on your own. Bring any restriction plan to your own physician first.

    The full trial numbers, including what each study could not show, sit in the book’s Deep Dive companion. The fuel those same bacteria are supposed to be making is covered in what a flagged butyrate result really samples, and the metabolic pattern behind the wall measurement above is in what insulin resistance looks like before diabetes.

    Frequently asked questions

    Is there a test that shows my emulsifier exposure?

    No, and that includes Measura. Exposure in the research is estimated from food records or labels, not from a sample of you, and the mouse work suggests the action sits in the mucus layer that stool sequencing cannot reach. Reading your own labels for a week is closer to a real exposure measurement than any panel currently sold. What Measura actually measures.

    Are emulsifiers causing my symptoms?

    Possibly contributing, and the honest answer stops short of proof. Because the effect is routed through gut bacteria, how much it matters varies with the microbes a person carries and how inflamed their metabolism already is. In healthy volunteers fed one purified emulsifier for eleven days, the main barrier measure did not move, while abdominal discomfort after meals did. Understanding your results.

    Which additive should I cut first?

    Cut items rather than chemicals. The exposure arrives as a cluster several times a day, and the compounds with the strongest laboratory signal are not the ones the large population studies name. Carrageenans and gums did the worst damage to microbial behavior in the screening work, and both turn up in ordinary yogurt, dressings and low-fat desserts. Who should be tested.

    My weight is stable, so is my gut wall fine?

    Weight is the weakest of the three signals measured. In the colonoscopy study, bacteria sat closer to the lining in step with hemoglobin A1c and fasting glucose, while obesity alone showed nothing and body mass index explained the least. That is an argument for measuring what your weight is made of rather than what it says. Body composition is not the same as weight.

    What should I ask my own physician?

    Ask whether your inflammatory markers, A1c and triglycerides suggest the inflamed baseline that the clean trials excluded, and how you would tell whether a change in food helped because the additives came out or because the fiber went in. Both moved together in every study, and they are separable at your kitchen table. Questions worth asking your doctor.

    What are the most common emulsifiers in food?

    In a study of 106,489 French adults, the most widely eaten were lecithins, reaching 86.6% of people, mono- and diglycerides of fatty acids at 78.1%, carrageenan at 77.5% and the phosphate group at 70.1%. They rarely arrive alone. People met them in recognizable clusters, several times a day, for years, so the real exposure is the whole mixture rather than any one chemical.

    Which foods are high in emulsifiers?

    Items with ingredient lists are where they live, and items with none are the way out. Carrageenans and gums, the compounds that did the worst damage to microbial behavior in laboratory screening, turn up in ordinary yogurt, dressings and low-fat desserts. Reading your own labels for a week, and counting the distinct additives you meet in a day, shows where your exposure actually comes from.

    Are emulsifiers in food bad for you?

    The harm runs through your bacteria, not straight through the chemical. In mice with no gut bacteria, emulsifiers did not thin the mucus, while a cultured human microbial community grew more inflammatory once cellulose gum was added. In the one human trial, healthy volunteers kept their barrier distance but their microbes, stool chemistry and after-meal comfort changed. How much it matters depends on the body meeting it.

    Measure the body that meets the label

    If your diet looks good on paper and you still feel inflamed, ask about Measura metabolic and body composition testing, with the findings sent to your own physician.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Chazelas, E., Druesne-Pecollo, N., Esseddik, Y., de Edelenyi, F. S., Agaesse, C., De Sa, A., Lutchia, R., Rebouillat, P., Srour, B., Debras, C., Wendeu-Foyet, G., Huybrechts, I., Pierre, F., Coumoul, X., Julia, C., Kesse-Guyot, E., Alles, B., Galan, P., Hercberg, S., … Touvier, M. (2021). Exposure to food additive mixtures in 106,000 French adults from the NutriNet-Sante cohort. Scientific Reports, 11(1), 19680. https://doi.org/10.1038/s41598-021-98496-6
    • Jawhara, M., Sorensen, S. B., Heitmann, B. L., Halldorsson, T. I., Pedersen, A. K., & Andersen, V. (2020). The relation between red meat and whole-grain intake and the colonic mucosal barrier: A cross-sectional study. Nutrients, 12(6), 1765. https://doi.org/10.3390/nu12061765
    • Chassaing, B., Raja, S. M., Lewis, J. D., Srinivasan, S., & Gewirtz, A. T. (2017a). Colonic microbiota encroachment correlates with dysglycemia in humans. Cellular and Molecular Gastroenterology and Hepatology, 4(2), 205-221. https://doi.org/10.1016/j.jcmgh.2017.04.001
    • Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M., & Gewirtz, A. T. (2017b). Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut, 66(8), 1414-1427. https://doi.org/10.1136/gutjnl-2016-313099
    • Chassaing, B., Compher, C., Bonhomme, B., Liu, Q., Tian, Y., Walters, W., Nessel, L., Delaroque, C., Hao, F., Gershuni, V., Chau, L., Ni, J., Bewtra, M., Albenberg, L., Bretin, A., McKeever, L., Ley, R. E., Patterson, A. D., Wu, G. D., … Lewis, J. D. (2022). Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome. Gastroenterology, 162(3), 743-756. https://doi.org/10.1053/j.gastro.2021.11.006
    • Chassaing, B., Koren, O., Goodrich, J. K., Poole, A. C., Srinivasan, S., Ley, R. E., & Gewirtz, A. T. (2015). Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature, 519(7541), 92-96. https://doi.org/10.1038/nature14232
    • Hall, K. D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K. Y., Chung, S. T., Costa, E., Courville, A., Darcey, V., Fletcher, L. A., Forde, C. G., Gharib, A. M., Guo, J., Howard, R., Joseph, P. V., McGehee, S., Ouwerkerk, R., Raisinger, K., … Zhou, M. (2019). Ultra-processed diets cause excess calorie intake and weight gain: An inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism, 30(1), 67-77.e3. https://doi.org/10.1016/j.cmet.2019.05.008
    • Desai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., Young, V. B., Henrissat, B., Wilmes, P., Stappenbeck, T. S., Nunez, G., & Martens, E. C. (2016). A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell, 167(5), 1339-1353.e21. https://doi.org/10.1016/j.cell.2016.10.043
    • Salame, C., Javaux, G., Sellem, L., Viennois, E., de Edelenyi, F. S., Agaesse, C., De Sa, A., Huybrechts, I., Pierre, F., Coumoul, X., Julia, C., Kesse-Guyot, E., Alles, B., Fezeu, L. K., Hercberg, S., Deschasaux-Tanguy, M., Cosson, E., Tatulashvili, S., Chassaing, B., … Touvier, M. (2024). Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Sante prospective cohort study. The Lancet Diabetes & Endocrinology, 12(5), 339-349. https://doi.org/10.1016/S2213-8587(24)00086-X

    Related reading

  • Dr. Gurpreet Singh Padda beside the title card reading A Waistline Predicted a Leaking Brain, The Angry Gut, Chapter 12

    Leaky Blood-Brain Barrier: The Body Numbers That Predict It Early

    A Waistline Predicted a Leaking Brain | The Angry Gut, Chapter 12

    Leaky Blood-Brain Barrier: The Body Numbers That Predict It Early

    A leaky blood-brain barrier is predicted early by ordinary body numbers: among initially healthy older adults, a larger body mass index and a higher waist-to-hip ratio went with a leaking barrier two decades on, and in 1,015 people the leak followed diabetes rather than amyloid.

    No office test can see the seal around your brain’s blood vessels. The forces that pry it open, though, show up in numbers most memory visits never collect.

    Researchers can now watch contrast dye seep out of the smallest brain blood vessels in living people, and the first region to show it is the hippocampus, where new memories are filed. A leaky blood-brain barrier sounds like something only a research scanner could find. What predicts it is far more ordinary. Among older adults who were healthy at the start, heavier bodies and wider waists relative to hips foretold a leaking barrier twenty years on.

    That thread runs through the video A Waistline Predicted a Leaking Brain, drawn from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service. It measures; your physician interprets and treats. So the question here is narrow. If nobody can check the barrier at an ordinary appointment, which of the forces behind it can be put on paper?

    What is a leaky blood-brain barrier?

    The blood-brain barrier is the tightly sealed lining of the brain’s capillaries. It decides what passes from your bloodstream into brain tissue. Dr. Padda admits he once sketched it for trainees as a solid row of bricks, and living-patient imaging retired that sketch. With dynamic contrast MRI, older adults whose memory still tested normal showed permeability 41% higher in the hippocampus than young controls, and 107% higher in one of its subfields. In mild cognitive impairment, those regions rose further, by 24%, 53% and 27%, compared with age-matched peers.

    The book gives this a precise vocabulary. The gut is the first brain. The organ in your skull is the second brain. The barrier is one of the borders between them, and what crosses it is best described as traffic: bacterial products and immune signals. A colony of bacteria living in a healthy brain has not been shown, and the most carefully controlled laboratory work argues against one.

    Does a leaky blood-brain barrier show up before symptoms?

    This is the finding that should change how you read a normal lab report. Among the volunteers with a leaking hippocampus, researchers also sampled spinal fluid, looking for familiar inflammatory messengers such as interleukin-6 and tumor necrosis factor. None had budged. Two things had: a marker of injury to pericytes, the cells that keep the barrier’s seams closed, which was up 115% in mild impairment, and the spinal fluid albumin ratio, up 30%.

    A follow-up study of 161 people found no difference between impaired and unimpaired groups across 20 markers of inflammation and nerve degeneration, while the barrier measure still predicted who was impaired. The door opens first; inflammation shows up later. A clean inflammation panel does not prove the seal is intact.

    What causes a leaky blood-brain barrier?

    An older method compares albumin in spinal fluid with albumin in blood. Across 1,015 people, that ratio did not change in early Alzheimer’s disease and did not follow amyloid imaging or the APOE gene. It followed diabetes, and it rose alongside proteins that a strained blood-vessel lining sheds. A separate small study of type 2 diabetes found brain permeability already elevated before any vessel damage appeared on a conventional scan, and recent blood sugar control explained none of it.

    Two biological drivers run through that record. One is years of high insulin and glucose load, the engine of metaflammation. The other is a vessel lining worn thin by that load. The third driver is not biological at all: a food supply engineered and subsidized to grow waistlines puts the problem in the pantry decades before it reaches a neurology office. The care system then splits the evidence. Your bowel belongs to one specialist, your memory to another, and your waist measurement to nobody.

    What a routine memory visit records, and what it skips

    A first visit for a memory complaint usually means a short screening test and a look at your medication list, sometimes followed by a brain scan. A borderline score often ends with advice to return in a year. What rarely gets written down are the numbers the barrier research keeps pointing toward: how much of your weight is fat, your fasting insulin, and whether either has drifted over a decade.

    Be clear about the limit. Measura does not image the brain and does not measure barrier permeability. No office test does. That work belongs to research scanners and spinal fluid studies, and those two methods do not always agree with each other. What can be measured is the terrain those studies connect to the leak.

    The measurements that close the gap

    • Bioimpedance body composition estimates how much of you is fat mass and how much is lean tissue. A bathroom scale and a body mass index chart cannot separate the two, and the barrier cohorts pointed at body shape, not weight alone.
    • Laboratory panels put numbers on the metabolic side, such as fasting insulin and blood sugar markers, so the insulin load is measured rather than assumed.
    • Arterial stiffness and endothelial function testing looks at how rigid your arteries are and how the vessel lining responds. It does not examine brain vessels, but the leak tracked vessel-lining strain, which makes your body’s own arteries a reasonable place to look.
    • Cognitive assessment gives memory, attention and processing speed a recorded baseline, so a borderline result becomes a starting line instead of a waiting period.

    The brain-fuel side of memory is covered in what a normal blood sugar test can miss, and the reason a first score matters is laid out in what a cognitive baseline is for. Every result goes to your physician, who decides what it means for you. None of it is a reason to start or stop a medication on your own.

    What to bring to your next appointment

    The woman at the center of the video lived with bowel trouble for sixteen years before she ever raised a memory concern. Her sequence is worth copying as a habit.

    1. The year your bowel habits changed and the year your memory did. Years, not decades.
    2. Your waist measurement and weight history, and whether either moved in the last ten years.
    3. A request to check fasting insulin during the same visit as the memory complaint.
    4. A question about body composition, since two people at the same weight can carry very different amounts of fat.

    The levers that move these numbers are food, meal timing, sleep and movement. No trial has yet shown that shrinking a waist narrows hippocampal leakage; the argument rests on mechanism and long cohorts, and acting on it does not have to wait. Every study with its limits is in the Chapter 12 Deep Dive. Clinicians can read the physician version of this screening question, and the next piece follows what fear does to digestion, measured.

    Frequently asked questions

    Can a blood test show a leaky blood-brain barrier?

    No routine blood test can. Research teams use contrast MRI or compare albumin in spinal fluid and blood, and the two methods do not always agree. In people whose hippocampus was already leaking, common inflammatory markers had not moved. Blood work is more useful for the drivers linked to the leak, such as fasting insulin and blood sugar. See how insulin resistance is measured.

    Is waist size linked to memory problems?

    Among initially healthy older adults, a larger body mass index and a higher waist-to-hip ratio went with a leaking barrier two decades on, and in 1,015 people the leak followed diabetes rather than amyloid. That is an association, not proof that waist size causes memory loss. It does make body shape, and the fat behind it, worth measuring. Learn why body composition says more than BMI.

    Can Measura test my blood-brain barrier?

    No. Measura does not image the brain or measure barrier permeability, and no office-based test does. It measures the terrain research ties to the leak: body composition, metabolic blood work, arterial stiffness and vessel-lining function, plus a cognitive baseline. Results go to your physician, who decides whether anything needs further workup elsewhere. Read about memory and cognitive screening.

    Are bacteria getting into the brain?

    When one laboratory reran brain tissue with strict contamination controls, 54.8% of what looked like bacterial DNA had arrived with the lab reagents, and another 34.2% turned out to be human DNA that software had mislabeled. Molecules shed by bacteria, along with immune messengers, can still cross a weakened seal; what has not been shown is bacteria actually living there. See what any test result can and cannot tell you.

    My memory score was borderline. Should I just wait a year?

    A borderline score is a reason to record where you stand, not to stop asking. Barrier changes appeared in the hippocampus of people whose memory still tested normal, and the drivers linked to them, insulin load and body fat, can be measured now. Ask your physician whether a baseline and metabolic numbers make sense for you. Read which dementia risk numbers you can measure today.

    What are the symptoms of a leaky blood-brain barrier?

    Often there are none at first. In living-patient imaging, older adults whose memory still tested normal already showed hippocampal permeability 41% higher than young controls, and the leak rose further in mild cognitive impairment. Common inflammation markers had not moved, so a clean lab report does not prove the seal is intact. That is why the body numbers tied to the leak are worth recording before memory slips.

    How do you fix a leaky blood-brain barrier?

    No trial has yet shown that shrinking a waist narrows hippocampal leakage. The case rests on mechanism and long cohorts, and acting on it does not have to wait. The levers that move the linked numbers are food, meal timing, sleep and movement. Measuring body composition, fasting insulin and vessel-lining function gives you and your physician a baseline to see whether those numbers move.

    Measure the terrain behind a memory complaint

    Ask about Measura body composition, metabolic and cognitive testing, with results sent to the physician evaluating your memory.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., Harrington, M. G., Chui, H. C., Law, M., & Zlokovic, B. V. (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron, 85(2), 296-302. https://doi.org/10.1016/j.neuron.2014.12.032
    • Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Chui, H. C., Law, M., Toga, A. W., & Zlokovic, B. V. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine, 25(2), 270-276. https://doi.org/10.1038/s41591-018-0297-y
    • Janelidze, S., Hertze, J., Nägga, K., Nilsson, K., Nilsson, C., Wennström, M., van Westen, D., Blennow, K., Zetterberg, H., & Hansson, O. (2017). Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiology of Aging, 51, 104-112. https://doi.org/10.1016/j.neurobiolaging.2016.11.017
    • Chen, Y. C., Lu, B. Z., Shu, Y. C., & Sun, Y. T. (2022). Spatiotemporal dynamics of cerebral vascular permeability in type 2 diabetes-related cerebral microangiopathy. Frontiers in Endocrinology, 12, 805637. https://doi.org/10.3389/fendo.2021.805637
    • Bedarf, J. R., Beraza, N., Khazneh, H., Ozkurt, E., Baker, D., Borger, V., Wullner, U., & Hildebrand, F. (2021). Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson’s disease individuals. Microbiome, 9(1), 75. https://doi.org/10.1186/s40168-021-01012-1

    Related reading

  • Title card for Your Gut Is Reaching Your Spine, The Angry Gut Chapter 11, with Dr. Padda presenting

    Crohn’s Disease Back Pain: What Scans Miss and What to Measure

    Your Gut Is Reaching Your Spine | The Angry Gut, Chapter 11

    Crohn’s Disease Back Pain: What Scans Miss and What to Measure

    Crohn’s disease can cause back pain, largely through inflammation. Across 71 pooled studies of inflammatory bowel disease, about 10% of people had sacroiliitis, inflammation where the spine meets the pelvis, and 3% had ankylosing spondylitis; the pain tends to follow an inflammatory pattern rather than a mechanical one.

    Back pain in someone with Crohn’s disease or colitis is usually scanned as a mechanical problem. The inflammatory pattern that points back to the bowel lives in the history, not the MRI.

    Crohn’s disease back pain often gets the same workup as anyone’s back pain: an MRI, physical therapy, perhaps an injection. The scans come back showing wear that most adults carry, and the bowel diagnosis sitting in the same chart never enters the conversation.

    The video above, Your Gut Is Reaching Your Spine, is Chapter 11 of The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. It follows a man whose colitis and eleven years of back pain were never discussed together. The question here is about measurement: what shows bowel inflammation reaching the spine, what a Measura [Cardiometabolic and Autonomic Health Analysis] visit cannot show, and what it can.

    How often does Crohn’s disease affect the spine?

    This part is not a theory. Across 71 pooled studies of people with inflammatory bowel disease, about 10% had sacroiliitis, inflammation where the spine meets the pelvis, 3% had ankylosing spondylitis and 13% had arthritis in the limbs. When researchers combined 52 studies covering 352,454 patients, roughly a quarter (24%) had some complication beyond the bowel; the share was 35% in Crohn’s disease and 27% in ulcerative colitis.

    Genes sort the risk. In ulcerative colitis, people carrying the HLA-B27 gene had a relative risk of 22.17 for developing ankylosing spondylitis. Rats engineered to carry that human gene develop gut and joint inflammation, but animals raised with no bacteria at all developed neither. That is animal work, a proof of principle, and it says the bacteria of the first brain are needed for the joint disease in a susceptible body.

    What does Crohn’s back pain feel like?

    Inflammatory back pain has a signature, and it is found by asking, not imaging. Pain that wakes you in the second half of the night. Morning stiffness lasting longer than half an hour. Pain that eases when you move and worsens when you rest, which is backward for a mechanical back. And the question almost nobody asks: has anyone linked it to your bowel?

    Meanwhile the MRI is crowded with findings that do not sort people. A Modic change, a signal change in the bone beside a disc, turns up in roughly 6% of people without pain, against a median 43% among people who hurt. Type 1 raised the odds of back pain about fourfold (4.01); a Modic change of unstated type came in at 1.62, an estimate that includes no effect at all. A scan shows where the spine has changed. It rarely tells anyone why it hurts.

    What Measura does not measure

    Be clear about the limits. Measura does not do imaging, so there is no MRI or X-ray of the sacroiliac joints. It does not do colonoscopy, stool testing or microbiome sequencing. It does not run genetic tests such as HLA-B27. Those belong to your physician, a gastroenterologist or a rheumatologist, ordered elsewhere. Anyone offering to read your bowel’s effect on your spine from one stool census is selling more certainty than the science holds.

    What Measura can show in the same person

    What a testing visit adds is the terrain the inflammation lives in. Laboratory panels capture metabolic blood work that can reflect insulin resistance and metaflammation, the slow-burning inflammation of metabolic disease. Bioimpedance body composition separates fat from muscle, compartments a bathroom scale lumps together. Heart rate variability measures the beat-to-beat variation that reflects how the autonomic nervous system balances stress and recovery, which matters in someone whose pain breaks up sleep night after night.

    None of those numbers diagnoses spinal arthritis. They answer a different question: how hot the terrain is running while specialists look at separate organs. For how insulin resistance ties into long-running pain, see chronic pain and metabolic health; for sleep, heart rhythm and related complaints, see autonomic symptoms.

    Do bacteria in the spinal disc cause back pain?

    Sequencing has found bacterial DNA in nearly every disc tested, even in donor discs that looked normal on MRI, which retires the idea that discs are sterile. Whether those bacteria cause pain is a separate matter. A disc has no blood supply, so a pill barely reaches it. In a large antibiotic trial for back pain with Modic changes, the researchers’ own bar for a meaningful change was 4 points; the result was 1.6, and drug-related side effects ran 56% against 34%. A 2026 trial of the same drug found adverse events in 40.0% of people taking it and 23.5% on placebo, without a pain benefit at twelve months.

    Do not start antibiotics on your own for back pain. What is established is inflammation traveling from bowel to spine, so getting the bowel disease under control is part of caring for the back.

    The first brain end of the problem

    The book calls the gut the first brain and the skull the second, and the spine sits downstream of the first. Several drivers keep that first brain inflamed. Diets heavy in acellular carbohydrates leave the short-chain fatty acid producers underfed, and those compounds are what the gut lining burns. Industrial seed oils feed metaflammation. Night pain that breaks up sleep belongs on the list too. Then the social driver: a system that sends the bowel to one specialist and the spine to another, so the patient ends up as the only person holding the whole file.

    The barrier those drivers wear down is the subject of the gut wall, and malabsorption from the same bowel drives the low vitamin D covered in what low vitamin D means.

    What should you ask your doctor about Crohn’s and back pain?

    If you live with Crohn’s disease or ulcerative colitis and your back hurts, ask whether anyone has looked at your sacroiliac joints specifically. Ask whether an HLA-B27 test or a rheumatology referral makes sense for your pain pattern. Ask what your inflammatory markers have done across years, not just this month. And ask for the metabolic and autonomic picture to be measured, so the terrain is documented instead of assumed. Unmeasured is unmanaged. The full study list sits in the Chapter 11 Deep Dive.

    Frequently asked questions

    Can Crohn’s disease cause back pain?

    Yes, largely through inflammation. Across 71 studies of inflammatory bowel disease, about one person in ten had sacroiliitis and 3% had ankylosing spondylitis, and complications outside the bowel were most common in Crohn’s disease. The back pain tends to follow an inflammatory pattern rather than a mechanical one. A starting point for matching symptoms to measurements is who should be tested.

    How is inflammatory back pain different from ordinary back pain?

    Inflammatory back pain usually wakes people in the later part of the night, brings morning stiffness lasting over half an hour, and feels better once you get moving but worse after sitting still. Mechanical back pain tends to run the opposite way. Write the pattern down before your appointment, because a scan will not record it. Help organizing that conversation is in questions worth asking your doctor.

    Can a Measura test show whether my bowel is affecting my spine?

    No single test can, and Measura does not do imaging, colonoscopy, stool tests or genetic tests like HLA-B27. What it can measure is the surrounding terrain: metabolic blood work, body composition and autonomic function, which your physician weighs alongside the specialist workup. A plain overview of the test library is in what Measura actually measures.

    Will antibiotics fix back pain if bacteria are in the disc?

    The evidence does not support that for most people. A large trial found a difference well below its own threshold for mattering to patients, with more side effects on the drug, and a 2026 trial found no pain benefit at twelve months. A disc has no blood supply, so medication barely reaches it. Never start or stop a medication on your own. Reading any single result in context is covered in understanding your results.

    Should someone with ulcerative colitis and back pain ask about HLA-B27?

    It is a fair question for your physician. In ulcerative colitis, carrying HLA-B27 was linked to a relative risk of 22.17 for ankylosing spondylitis, though only a few studies reported the gene. Your physician orders that test; it is not one Measura performs. Inflammation and metabolic risk often travel together, as insulin resistance and metabolic health explains.

    Where is Crohn’s back pain usually felt?

    The inflammatory kind centers on the sacroiliac joints, where the spine meets the pelvis. Across 71 pooled studies of inflammatory bowel disease, about 10% of people had sacroiliitis and 3% had ankylosing spondylitis, while 13% had arthritis in the limbs. Ask whether anyone has looked at your sacroiliac joints specifically, because a general spine scan may not answer that question.

    How do you relieve back pain from Crohn’s disease?

    Start at the source. What is established is inflammation traveling from the bowel to the spine, so getting the bowel disease under control is part of caring for the back. Ask your physician about the sacroiliac joints, an HLA-B27 test or a rheumatology referral, and about your inflammatory markers across years. Do not start antibiotics on your own; the disc trials did not show a meaningful benefit.

    Why doesn’t my MRI explain my back pain?

    Because the MRI is crowded with findings most adults carry. A Modic change, a signal change in the bone beside a disc, turns up in roughly 6% of people without pain and a median 43% of people who hurt. A scan shows where the spine has changed; it rarely tells anyone why it hurts. The inflammatory pattern that points to the bowel lives in your history, not the image.

    Measure the Terrain Around the Pain

    Ask about laboratory panels, body composition and heart rate variability testing so the metabolic and autonomic picture is documented alongside your specialist care. Results go to your physician.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Karreman, M. C., Luime, J. J., Hazes, J. M. W., & Weel, A. E. A. M. (2017). The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn’s & Colitis, 11(5), 631–642. https://doi.org/10.1093/ecco-jcc/jjw199
    • Kilic, Y., Kamal, S., Jaffar, F., Sriranganathan, D., Quraishi, M. N., & Segal, J. P. (2024). Prevalence of extraintestinal manifestations in inflammatory bowel disease: A systematic review and meta-analysis. Inflammatory Bowel Diseases, 30(2), 230-239. https://doi.org/10.1093/ibd/izad061
    • Lin, A., Tan, Y., Chen, J., Liu, X., & Wu, J. (2023). Development of ankylosing spondylitis in patients with ulcerative colitis: A systematic meta-analysis. PLoS One, 18(8), e0289021. https://doi.org/10.1371/journal.pone.0289021
    • Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. The Journal of Experimental Medicine, 180(6), 2359–2364. https://doi.org/10.1084/jem.180.6.2359
    • Jensen, T. S., Karppinen, J., Sorensen, J. S., Niinimäki, J., & Leboeuf-Yde, C. (2008). Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain. European Spine Journal, 17(11), 1407–1422. https://doi.org/10.1007/s00586-008-0770-2
    • Brinjikji, W., Diehn, F. E., Jarvik, J. G., Carr, C. M., Kallmes, D. F., Murad, M. H., & Luetmer, P. H. (2015). MRI findings of disc degeneration are more prevalent in adults with low back pain than in asymptomatic controls: A systematic review and meta-analysis. AJNR. American Journal of Neuroradiology, 36(12), 2394–2399. https://doi.org/10.3174/ajnr.A4498
    • Bråten, L. C. H., Rolfsen, M. P., Espeland, A., Wigemyr, M., Aßmus, J., Froholdt, A., Haugen, A. J., Marchand, G. H., Kristoffersen, P. M., Lutro, O., Randen, S., Wilhelmsen, M., Winsvold, B. S., Kadar, T. I., Holmgard, T. E., Vigeland, M. D., Vetti, N., Nygaard, Ø. P., Lie, B. A., … Zwart, J.-A. (2019). Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial. BMJ, 367, l5654. https://doi.org/10.1136/bmj.l5654
    • Cicuttini, F. M., Wluka, A. E., Pan, F., O’Sullivan, R., Leder, K., Cheng, A. C., & Urquhart, D. M. (2026). Efficacy of antibiotics for chronic low back pain with disc herniation: a randomized clinical trial. JAMA Network Open, 9(5), e2612848. https://doi.org/10.1001/jamanetworkopen.2026.12848
    • Rajasekaran, S., Vasudevan, G., Easwaran, M., Devi Ps, N., Anand K S, S. V., Murugan, C., Shetty, A. P., Kanna, R. M., & Tangavel, C. (2023). “Are we barking up the wrong tree? Too much emphasis on Cutibacterium acnes and ignoring other pathogens” – a study based on next-generation sequencing of normal and diseased discs. The Spine Journal, 23(10), 1414–1426. https://doi.org/10.1016/j.spinee.2023.06.396

    Related reading

  • Dr. Gurpreet Singh Padda beside the Chapter 8 title card of The Angry Gut reading Your Gut Wall Is What You Fried Last Week.

    Are Seed Oils Bad for You? What Your Numbers Can Actually Show

    Your Gut Wall Is What You Fried Last Week | The Angry Gut, Chapter 8

    Are Seed Oils Bad for You? What Your Numbers Can Actually Show

    Seed oils are neither poison nor simply safe. Their omega-6 fats oxidize easily and supply the raw material for inflammatory signals, so the concern is exposure: how much of your fat comes from these oils, and how often that oil was heated and reused before you ate it.

    The fight over seed oils is mostly a fight over measurement: which oil, in what condition, read by which test. Your gut wall and your arteries keep a record that argument rarely checks.

    Are seed oils bad for you? The question usually gets asked as if oil in a sealed bottle, oil in a restaurant fryer on its fourth day and a fatty acid in a blood sample were the same thing. They are not, and most of the shouting comes from treating them as one exposure. The gut side of that argument plays out in Your Gut Wall Is What You Fried Last Week, drawn from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. The question here is practical: what can be measured in you, and what a result is allowed to mean.

    Are seed oils bad for you? Poison and safe are both wrong

    Industrial seed oils are rich in omega-6 fats. Those fats are chemically reactive. They oxidize easily, and they supply the raw material for the signals that switch inflammation on. None of that makes a bottle of oil a toxin, and Dr. Padda does not call it one. His position is about exposure: how much of your fat comes from these oils, how often that oil was heated and reused before you ate it, and whether anything else on your plate balances it.

    The studies that reassure people usually count something different. A blood test for a fatty acid reads the intact molecule that survived, typically drawn once, and it cannot tell fresh oil from oil that sat in a fryer all week. Such a study can clear the fatty acid and still say nothing about the degraded oil most people eat. Researchers call that exposure misclassification. It is a reason to ask what any number, in a study or on your report, was really counting.

    How do seed oils affect your gut?

    Your gut is the first brain, and your skull holds the second. The first brain rebuilds its lining every few days from fatty acids that arrived recently. Membrane fat is not stored fuel; it is the stock from which inflammatory signals are cut, so the fats on hand shape the message sent. A lining built mostly from omega-6 fat is primed to start inflammation, and the same raw material reaches your arteries, where insulin resistance and high triglycerides may already strain the system.

    That is metaflammation with a supply chain. Fryer oil in a hospital cafeteria is cheap because the crop behind it is subsidized, and the night-shift worker eating fried food most days did not set that price or choose that oil. Biology decides what the membrane does with the fat. Economics decides which fat arrives.

    What a standard visit checks, and what it misses

    A visit for loose stools and belly pain usually ends with a scope, a stool sample or a referral. Those tests look for disease in the bowel. None of them asks what the wall is being built from, and none is designed to. A routine physical adds a cholesterol panel, which describes fat-carrying particles in the blood, not the makeup of a gut membrane.

    Even research labs struggle here. In ulcerative colitis, the protective mucus of the colon held 745 pmol of its main waterproofing lipid per 100 µg of protein, compared with 2,790 in healthy people. A drug designed to replace that lipid was stopped in phase 3 because it did not help. A survey of 584 lipid species pointed to the reason: the colon mostly makes that lipid itself. A low level in the tissue did not mean the diet was short of it.

    The inflammation off switch makes the same point harder. Resolvins are molecules cut from fat that help end inflammation. Read by mass spectrometry, resolvin D1 comes in around 30 pg/ml. Read by the antibody kits much of the human research relied on, it comes in above 2,000 pg/ml, because those kits also pick up neighboring lipids. A confident figure from the wrong method is worse than no figure, because it stops the search.

    What can be measured in the same person

    Nobody can sample your gut wall at a screening visit, and Measura [Cardiometabolic and Autonomic Health Analysis] does not try. What can be measured is the terrain that the same fat supply feeds: how your body handles fat and sugar, how your arteries behave, and where your weight actually sits.

    None of these reads your omega-6 to omega-3 balance or diagnoses a bowel disease. A blood fatty acid profile is a separate laboratory question for your physician, and gut symptoms still need their own workup. What Measura shows is whether the metabolic and vascular picture around your gut is quiet or already strained, and the findings go to your physician. What a test result can and cannot tell you covers that boundary, and insulin resistance and metabolic health explains why the terrain matters.

    Why isn’t a fish oil capsule the answer?

    Dr. Padda spent years as a strict vegetarian cooking in the oils the guidelines approved, and he gave patients that same advice. What changed his mind was pathology, not a headline. He is just as blunt about the opposite shortcut. Fish oil changes membrane makeup quickly, but in Crohn’s disease two large trials enrolling 738 patients at 98 centers saw relapse at 31.6% on fish oil versus 35.7% on placebo in the first trial. Pooled across long-term heart trials, marine omega-3 supplements raised atrial fibrillation, with a hazard ratio of 1.49 above 1 g a day. A pill that nudges one number while adding a rhythm risk is not a plan.

    What he uses instead is the kitchen: a different cooking oil, far less restaurant frying, and the fish and full-fat dairy a rushed diet dropped. Changing food changes the same membranes, meal after meal, with no drug-sized dose.

    What tests should you ask for if you eat a lot of fried food?

    • If you eat fried or restaurant food most days, ask whether your blood work includes triglycerides, HDL cholesterol and fasting insulin, not only total cholesterol.
    • If you take fish oil above 1 g a day, bring the dose and your reason for taking it to your physician.
    • If your metabolic numbers are drifting and your arteries have never been measured, ask whether vascular testing makes sense for you.
    • If gut symptoms have lasted for months, ask for a diagnosis before assuming the cause is your diet.

    The short version: seed oils are not poison, studies of fresh oil do not settle the question, and your own terrain can be measured. Questions worth asking your doctor helps you prepare, the full study-by-study evidence is on the Chapter 8 book companion page, and the blood supply those membranes depend on is the subject of what endothelial dysfunction means for your arteries.

    Frequently asked questions

    Are seed oils inflammatory?

    The omega-6 fats in seed oils are the raw material for signals that start inflammation, and they oxidize easily when oil is heated and reused. Whether that becomes a problem for you depends on how much of your fat comes from them, how degraded the oil was and what else you eat. One blood fatty acid reading cannot answer that alone. Chronic pain and metabolic health shows how inflammation and metabolism connect.

    Can a blood test show whether my diet is driving inflammation?

    Not directly. Blood work can show how your body handles fat and sugar through markers such as triglycerides, HDL cholesterol, glucose and insulin, and your physician can order a fatty acid profile separately. None of these reads the membranes of your gut. They describe the terrain around it, which is still worth knowing before you change anything. Which laboratory runs the blood work explains where samples go.

    Is fish oil a safe way to balance omega-6 and omega-3?

    Fish oil changes membrane makeup quickly, but it did not keep Crohn’s disease in remission in large trials, and pooled heart trials linked marine omega-3 supplements to more atrial fibrillation, especially above 1 g a day. Food changes the same membranes without a drug-sized dose. Do not start or stop a supplement without talking with your physician. Finding cardiovascular risk early covers the heart side.

    Why would my arteries matter for a gut problem?

    The fat supply that builds your gut lining also reaches the lining of your blood vessels, and your gut depends completely on blood flow to repair itself. Measuring how your arteries stiffen and open gives a view of the terrain your gut shares with the rest of your body, without claiming to look inside the bowel. Understanding your results walks through what a vascular finding means.

    Does whole-fat dairy help or hurt?

    Across 16 cohorts, people with more of the dairy fat C15:0 in their blood developed type 2 diabetes less often. That is an association, and the marker also reflects simply eating dairy. The scientist promoting C15:0 as an essential nutrient founded a company that sells it. Whole foods rather than powders is the practical reading. What insulin resistance looks like before diabetes explains the earlier warning signs.

    Should I stop using seed oils?

    Dr. Padda’s approach is to cut the exposure, not to fear a bottle. In practice that means a different cooking oil at home, far less restaurant frying, where oil is heated and reused for days, and bringing back the fish and full-fat dairy a rushed diet dropped. Changing food changes your membranes meal after meal, without a drug-sized dose. Talk with your physician before changing any supplement.

    What happens when you stop eating seed oils?

    Your gut lining rebuilds every few days from the fats that arrived recently, so a change in what you cook with reaches the membrane quickly. Membrane fat is the stock from which inflammatory signals are cut, so different fats on hand shape a different message. Measura cannot sample your gut wall, but blood work, arterial testing and body composition show whether the surrounding terrain is settling.

    Why is everyone against seed oils?

    Because their omega-6 fats are chemically reactive: they oxidize easily when oil is heated and reused, and they supply the raw material for inflammatory signals. The argument stays loud because the two sides measure different things. Reassuring studies usually read the intact fatty acid in a single blood draw, which cannot tell fresh oil from oil that sat in a fryer all week.

    Measure the terrain, not the argument

    Request Measura testing to see your metabolic and vascular numbers, and bring your questions about fat and your gut to your own physician.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Braun, A., Treede, I., Gotthardt, D., Tietje, A., Zahn, A., Ruhwald, R., Schoenfeld, U., Welsch, T., Kienle, P., Erben, G., Lehmann, W.-D., Fuellekrug, J., Stremmel, W., & Ehehalt, R. (2009). Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflammatory Bowel Diseases, 15(11), 1705–1720. https://doi.org/10.1002/ibd.20993
    • Moe, O. K., Gao, Q., Geng, D., Jensen, E., Goll, R., Nestegard, O., Gundersen, M. D., Meyer, R., Florholmen, J., & Hansen, T. (2025). Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study. BMC Gastroenterology, 25(1), 389. https://doi.org/10.1186/s12876-025-03944-6
    • Schebb, N. H., Kühn, H., Kahnt, A. S., Rund, K. M., O’Donnell, V. B., Flamand, N., Peters-Golden, M., Jakobsson, P.-J., Weylandt, K. H., Rohwer, N., Murphy, R. C., Geisslinger, G., FitzGerald, G. A., Hanson, J., Dahlgren, C., Alnouri, M. W., Offermanns, S., & Steinhilber, D. (2022). Formation, signaling and occurrence of specialized pro-resolving lipid mediators — what is the evidence so far? Frontiers in Pharmacology, 13, 838782. https://doi.org/10.3389/fphar.2022.838782
    • Feagan, B. G., Sandborn, W. J., Mittmann, U., Bar-Meir, S., D’Haens, G., Bradette, M., Cohen, A., Dallaire, C., Ponich, T. P., McDonald, J. W. D., Hébuterne, X., Paré, P., Klvana, P., Niv, Y., Ardizzone, S., Alexeeva, O., Rostom, A., Kiudelis, G., Spleiss, J., … Greenberg, G. R. (2008). Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials. JAMA, 299(14), 1690–1697. https://doi.org/10.1001/jama.299.14.1690
    • Gencer, B., Djousse, L., Al-Ramady, O. T., Cook, N. R., Manson, J. E., & Albert, C. M. (2021). Effect of long-term marine ɷ-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: A systematic review and meta-analysis. Circulation, 144(25), 1981–1990. https://doi.org/10.1161/CIRCULATIONAHA.121.055654
    • Imamura, F., Fretts, A., Marklund, M., Ardisson Korat, A. V., Yang, W.-S., Lankinen, M., Qureshi, W., Helmer, C., Chen, T.-A., Wong, K., Bassett, J. K., Murphy, R., Tintle, N., Yu, C. I., Brouwer, I. A., Chien, K.-L., Frazier-Wood, A. C., Del Gobbo, L. C., Djoussé, L., … Mozaffarian, D. (2018). Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS Medicine, 15(10), e1002670. https://doi.org/10.1371/journal.pmed.1002670
    • Venn-Watson, S. (2024). The cellular stability hypothesis: Evidence of ferroptosis and accelerated aging-associated diseases as newly identified nutritional pentadecanoic acid (C15:0) deficiency syndrome. Metabolites, 14(7), 355. https://doi.org/10.3390/metabo14070355

    Related reading

  • Dr. Gurpreet Singh Padda in a white coat beside the title card reading Chapter 5, The Angry Gut, Alcohol you never drank

    What Does Echogenic Liver Mean? Reading the Numbers Behind the Scan

    The Alcohol You Never Drank | The Angry Gut, Chapter 5

    What Does Echogenic Liver Mean? Reading the Numbers Behind the Scan

    Echogenic liver means the ultrasound shows a liver consistent with fatty liver, hepatic steatosis. Because the scan detects fat only once more than 30% of liver cells are loaded, the finding usually means substantial fat is already there, even when liver enzymes read normal.

    An ultrasound report calls your liver echogenic, and your enzymes are called normal. Both can be true while a fatty liver sits upstream of your heart and your metabolism.

    What does echogenic liver mean? On an ultrasound report, a liver described as diffusely echogenic is the radiologist’s way of saying it looks consistent with hepatic steatosis, a fatty liver. The video above, The Alcohol You Never Drank, is Chapter 5 of The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. It opens with the question almost everyone asks after that report: how does fat get into a liver when the person does not drink?

    Two things tend to arrive with the scan. The liver enzymes are called fine, and the advice is to lose weight. Both deserve a closer look, because neither tells you what put the fat there or what it is doing to the rest of your body.

    What does echogenic liver mean on the scan?

    Ultrasound is a blunt instrument for liver fat. British guidance on abnormal liver tests notes that the scan only picks up fat once more than 30% of liver cells are loaded. So an echogenic report usually means a substantial amount of fat is already there. The reverse matters too: a scan read as normal does not rule out milder fatty liver, especially when blood markers and metabolic risk factors point the other way.

    Liver imaging is done by the physician or imaging service that ordered it. What a picture of the liver cannot tell you is how the metabolism around that liver is behaving, and that part can be measured.

    How does fat get into the liver if you do not drink?

    Everything your bowel absorbs travels to the liver first, through the portal vein, before your heart sees any of it. The gut is the first brain, the skull holds the second, and when the gut is inflamed the liver hears about it first. Surgeons have sampled that vein. In patients having elective abdominal operations, portal blood carried endotoxin, a bacterial fragment the immune system treats as an alarm, in 97% of cases, while arm blood tested positive in just 4 of 34 people.

    Researchers later sampled the same vein for alcohol. In people having bariatric surgery, portal ethanol ran a median 187 times higher than fasting arm blood. Levels tracked the stage of disease: 21.0 mM in steatohepatitis, the inflamed stage, against 8.0 mM in simple fatty liver and 2.1 mM without liver fat. Gut organisms ferment sugar into alcohol, and a working liver clears it so quickly that an ordinary blood test never catches it.

    There is a fair counterargument. In children with early fatty liver, and in mice, the bigger difference was clearance rather than production: an insulin-resistant liver broke alcohol down more slowly. Either way the road runs through insulin, and nobody has yet run the clinical study that would prove cause and effect. The mechanism remains the best explanation for the patient that clean trials leave out.

    The supply side is economic. Subsidized crops make sweetener abundant, so food makers put it almost everywhere, and a gut that meets sugar at every meal never runs short of fermentation fuel.

    Why can liver enzymes be normal with an echogenic liver?

    The liver works as a filter around the clock, and blood drawn from the arm samples what that filter has already cleaned. That is one reason enzymes can look unremarkable beside an echogenic scan.

    One number on a standard panel reads the strain better than most. GGT, gamma-glutamyl transferase, sits on the cell surface and helps the cell rebuild its antioxidant supply, so a cell under oxidative stress makes more of it. In a Korean cohort of 9,687,066 adults followed a median 8.3 years, the highest third of GGT carried a hazard ratio of 1.33 for death from any cause after adjustment for alcohol, body mass index and other liver enzymes. For women, that highest third started at 21 IU/L, a value every laboratory prints as normal.

    GGT has honest limits. Obesity raises it more often than alcohol does, and people with genetically higher GGT were not more likely to develop diabetes or heart disease, so it reports strain rather than causing it. Its value is the trend: a GGT drifting upward inside the reference range over years says the system is working harder.

    Dr. Padda ended visits for years with the advice to lose some weight and believed he had done something useful. For someone who has already lost and regained the weight several times, one more instruction explains nothing about why fat went to the liver.

    Can you have a fatty liver at a normal weight?

    The calorie argument is real. In the largest randomized trial of a synbiotic for fatty liver, weight loss was the only factor that moved liver fat. But arithmetic cannot explain why two people with the same surplus end up with different livers, or why a South Asian man with a normal body mass index and thin limbs can carry a liver packed with fat while being told his weight is fine.

    What the liver responds to is delivery. Resistant starch, given for four months in a randomized trial, cut liver fat by 9.08%, and by 5.89% once weight loss was accounted for. In a small six-week study, inulin, a fermentable fiber, pushed liver fat up from 20.9% to 26.8%, most likely because gut bacteria turned it into acetate, a raw material the liver builds fat from. Two ways of feeding the gut, and the liver went in opposite directions.

    Weight is the wrong yardstick for a disease that follows delivery and insulin. That gap is exactly what body composition and metabolic laboratory work are built to fill.

    What Measura can measure around a fatty liver

    Measura [Cardiometabolic and Autonomic Health Analysis] does not image the liver; ultrasound and other liver imaging are done elsewhere. It measures the terrain a fatty liver sits in, and every finding goes to your physician:

    Measura does not diagnose fatty liver or treat it.

    What to bring to your next appointment

    • Every GGT result you can find, from as many years back as your records go. One value is a snapshot; several make a trend.
    • How much fat would my liver need before the ultrasound showed anything?
    • Has my insulin been measured, not only my glucose?
    • Can we look at my body composition rather than my weight alone?
    • Given my liver and my GGT, should my blood vessels be checked?

    More prompts are on questions worth asking your doctor. The wall that decides how much reaches the portal vein is covered in the previous post on testing for leaky gut, and what happens when the bowel cannot absorb what it is given comes next in the following post. Every study above, with what it cannot show, is in the Chapter 5 book companion. Unmeasured is unmanaged, and a normal enzyme beside an echogenic scan is a question, not an answer. Once fat is on the scan, the next question is scarring, and a routine blood panel can be turned into a fatty liver fibrosis score.

    Frequently asked questions

    Can you get a fatty liver without drinking alcohol?

    It happens. Bacteria and yeast in the bowel turn sugar into ethanol that flows straight to the liver, and surgical sampling found portal-vein alcohol many times higher than arm levels in people with fatty liver. Slower alcohol clearance by an insulin-resistant liver adds to the load. The insulin side of that picture is explained in insulin resistance and metabolic health.

    Can liver tests be normal with a fatty liver?

    Often. Arm blood is sampled after the liver has filtered what came from the gut, and ultrasound misses fat until more than 30% of liver cells carry it. A GGT creeping upward inside the reference range can be an earlier sign of strain. For why a normal result does not always settle a question, see what a test result can and cannot tell you.

    Is a GGT inside the reference range a healthy GGT?

    Not necessarily. In a cohort of more than nine million Korean adults, women in the highest third of GGT, starting at 21 IU/L, had a higher risk of death than women in the lowest third. Being inside the range and being healthy are two separate claims, and the trend over several years says more than one reading. See understanding your results.

    Does Measura do liver ultrasound?

    No. Liver imaging is done elsewhere, by the physician or imaging service that orders it. Measura measures the metabolic terrain around a fatty liver, including laboratory panels, body composition and vascular function, and sends every result to your physician. How the measurements for a given person are selected is described in how a testing plan is chosen.

    Why does body composition matter if my liver is fatty?

    Because weight hides where fat sits and how much muscle you carry. People with a normal body mass index can still be insulin resistant and have fat in the liver. Measuring fat and muscle separately shows a pattern the scale cannot, and repeat measurements show whether changes are working. See body composition is not the same as weight.

    Is echogenic liver serious?

    It deserves attention. Ultrasound picks up fat only once more than 30% of liver cells are loaded, so an echogenic report usually means a substantial amount is already there, even when enzymes read normal. A fatty liver sits upstream of your heart and your metabolism: across 23 studies and more than a million people, higher GGT predicted cardiovascular death. Once fat is on the scan, the next question is scarring.

    How do you fix an echogenic liver?

    Start with what put the fat there. In the largest randomized synbiotic trial for fatty liver, weight loss was the only factor that moved liver fat; resistant starch taken for four months cut liver fat by 9.08%, while inulin pushed it up in a small study. Because the disease follows delivery and insulin, measuring insulin, body composition and a GGT trend shows whether your changes are working.

    Look past the scan

    Request Measura testing to see the metabolic, body composition and vascular numbers around your liver, with every result sent to your physician.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Newsome, P. N., Cramb, R., Davison, S. M., Dillon, J. F., Foulerton, M., Godfrey, E. M., Hall, R., Harrower, U., Hudson, M., Langford, A., Mackie, A., Mitchell-Thain, R., Sennett, K., Sheron, N. C., Verne, J., Walmsley, M., & Yeoman, A. (2018). Guidelines on the management of abnormal liver blood tests. Gut, 67(1), 6-19. https://doi.org/10.1136/gutjnl-2017-314924
    • Jacob, A. I., Goldberg, P. K., Bloom, N., Degenshein, G. A., & Kozinn, P. J. (1977). Endotoxin and bacteria in portal blood. Gastroenterology, 72(6), 1268–1270. https://pubmed.ncbi.nlm.nih.gov/858472/
    • Meijnikman, A. S., Davids, M., Herrema, H., Aydin, O., Tremaroli, V., Rios-Morales, M., Levels, H., Bruin, S., de Brauw, M., Verheij, J., Kemper, M., Holleboom, A. G., Tushuizen, M. E., Schwartz, T. W., Nielsen, J., Brandjes, D., Dallinga-Thie, G. M., Havik, S. R., Ackermans, M. T., … Nieuwdorp, M. (2022). Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nature Medicine, 28(10), 2100–2106. https://doi.org/10.1038/s41591-022-02016-6
    • Engstler, A. J., Aumiller, T., Degen, C., Durr, M., Weiss, E., Maier, I. B., Schattenberg, J. M., Jin, C. J., Sellmann, C., & Bergheim, I. (2016). Insulin resistance alters hepatic ethanol metabolism: Studies in mice and children with non-alcoholic fatty liver disease. Gut, 65(9), 1564–1571. https://doi.org/10.1136/gutjnl-2014-308379
    • Cho, E. J., Jeong, S.-M., Chung, G. E., Yoo, J.-J., Cho, Y., Lee, K.-N., Shin, D. W., Kim, Y. J., Yoon, J.-H., Han, K., & Yu, S. J. (2023). Gamma-glutamyl transferase and risk of all-cause and disease-specific mortality: a nationwide cohort study. Scientific Reports, 13(1), 1751. https://doi.org/10.1038/s41598-022-25970-0
    • Liu, J., Au Yeung, S. L., Lin, S. L., Leung, G. M., & Schooling, C. M. (2016). Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: A Mendelian randomization study. Scientific Reports, 6, 38813. https://doi.org/10.1038/srep38813
    • Rahmani, J., Miri, A., Namjoo, I., Zamaninour, N., Maljaei, M. B., Zhou, J. B., Shokouhi Nasab Kermani, R., Kord Varkaneh, H., Fatahi, S., & Zhang, Y. (2019). Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants. European Journal of Gastroenterology & Hepatology, 31(5), 555–562. https://doi.org/10.1097/MEG.0000000000001353
    • Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A., Childs, C. E., Del Fabbro, S., Bilson, J., Moyses, H. E., Clough, G. F., Sethi, J. K., Patel, J., Wright, M., Breen, D. J., Peebles, C., Darekar, A., Aspinall, R., Fowell, A. J., … Byrne, C. D. (2020). Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease. Gastroenterology, 158(6), 1597–1610.e7. https://doi.org/10.1053/j.gastro.2020.01.031
    • Ni, Y., Qian, L., Siliceo, S. L., Long, X., Nychas, E., Liu, Y., Ismaiah, M. J., Leung, H., Zhang, L., Gao, Q., Wu, Q., Zhang, Y., Jia, X., Liu, S., Yuan, R., Zhou, L., Wang, X., Li, Q., Zhao, Y., … Jia, W. (2023). Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Cell Metabolism, 35(9), 1530-1547.e8. https://doi.org/10.1016/j.cmet.2023.08.002
    • Chambers, E. S., Byrne, C. S., Rugyendo, A., Morrison, D. J., Preston, T., Tedford, C., Bell, J. D., Thomas, L., Akbar, A. N., Riddell, N. E., Sharma, R., Thursz, M. R., Manousou, P., & Frost, G. (2019). The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes, Obesity & Metabolism, 21(2), 372–376. https://doi.org/10.1111/dom.13500

    Related reading

  • Dr. Gurpreet Singh Padda beside the title card reading Your Anxiety Is a Fire in Your Gut, The Angry Gut, Chapter 1

    Can Inflammation Cause Anxiety? What Blood Work and Testing Show

    Your Anxiety Is a Fire in Your Gut | The Angry Gut, Chapter 1

    Can Inflammation Cause Anxiety? What Blood Work and Testing Show

    Inflammation can contribute to anxiety in a subset of people, not in everyone. That subset only shows up when someone measures, starting with inflammatory blood markers such as C-reactive protein chosen with your physician.

    Anxiety is usually treated as a problem inside the skull. A growing set of experiments says some of it is lit lower down, and part of that fire leaves marks in ordinary blood work.

    Can inflammation cause anxiety? In a subset of people the evidence says it can contribute, and that subset only shows up when someone measures. Dr. Padda’s video Your Anxiety Is a Fire in Your Gut argues that the gut, the first brain, can inflame the second brain in your skull. Measura [Cardiometabolic and Autonomic Health Analysis] asks the practical follow-up: what in your own numbers would show whether that argument applies to you?

    Can inflammation change your mood?

    The strongest human evidence is experimental. Healthy volunteers given a small dose of bacterial endotoxin, a fragment of the outer coat of gut bacteria, develop lower mood under placebo-controlled conditions. In a trial of one hundred and fifteen healthy adults randomized to endotoxin or saline, the people whose mood fell furthest already carried more perceived stress, more sensitivity to feeling socially cut off and more baseline anxiety. Their inflammatory chemicals did not rise any higher than everyone else’s. What differed was the size of the response.

    Hepatitis C clinics watched the same thing for two decades. Interferon, an inflammatory messenger given as treatment, brought on major depression in roughly one patient in four by 24 weeks, more often in people with a prior depressive episode or higher baseline interleukin-6.

    Can the gut trigger anxiety?

    Anxiety-like behavior has been produced from the gut lining itself. In mice, switching on enterochromaffin cells, the serotonin-releasing cells of the intestinal lining, made the gut hypersensitive and triggered anxiety-like behavior that settled once serotonin signaling was blocked. No serotonin had to reach the brain, and it could not have: although roughly 90 to 95 percent of all serotonin in the body is made in the gut, that supply does not cross the blood-brain barrier. The message travels on nerves, and through inflammation, which steers tryptophan away from the brain’s own serotonin supply.

    Dr. Padda admits he used to give patients the simpler story, that a gut making serotonin must be running their mood. The manufacturing half held up. The delivery half did not, and correcting it is what points toward inflammation as the link that can actually be measured.

    The wall of the first brain also answers to how people live. In healthy married couples, more hostile arguments went with more of a blood marker for bacterial fragments crossing the gut wall, and that marker tracked whole-body inflammation: 79 percent of people in its highest group had an average daytime CRP above 3, against 21 percent in its lowest. A food supply built on flour and sugar, stripped of fermentable fiber, adds fuel from the plate. Across The Angry Gut, that combined terrain goes by one name, metaflammation.

    Does inflammation cause anxiety in everyone?

    Inflammation does not explain everyone. Across 30 studies of people with depression, 27 percent had a C-reactive protein, or CRP, above 3 mg/L, the usual line for low-grade inflammation; at a cutoff of 1 mg/L the share was 58 percent. Those figures come from depression research rather than anxiety research, but the shape is the point: an inflamed minority exists, and nobody can see it without a blood draw. In one treatment trial, an antibody that blocks an inflammatory signal helped depressed patients only when their CRP sat above 5 mg/L.

    What does a routine anxiety visit miss?

    Anxiety is usually assessed with a conversation and a questionnaire, while digestive symptoms are sent to a different clinic. CRP and fasting insulin may never be drawn, and when they are, no one may connect them to mood. A stool microbiome report does not close that gap. Large microbiome studies of depression have replicated poorly, and the same bacterial shifts appear across depression, bipolar disorder, schizophrenia and anxiety alike. Measura does not offer stool, breath or microbiome tests.

    Which tests show whether inflammation is behind anxiety?

    • Laboratory panels report metabolic and inflammatory blood markers. Whether CRP and fasting insulin are included is decided with your physician, and one high CRP calls for a repeat, since infection, injury or a hard workout can also push it up.
    • Bioimpedance body composition separates fat from muscle, the tissue picture that tends to accompany high insulin and a widening waist.
    • Heart rate variability records beat-to-beat variation in your heart rate, a measure of how the autonomic nervous system is regulating at rest. It describes regulation; it does not diagnose anxiety.

    None of these tests diagnoses an anxiety disorder or replaces the clinician treating your mood. Every result goes to your physician, who decides what it means. What the numbers add is evidence about whether an inflamed, metabolically strained body sits underneath the symptom. For how results are read, see understanding your results.

    Questions to bring, and what not to change

    • Has my CRP ever been measured, and if it was above 3 mg/L, was it repeated and explained?
    • What is my fasting insulin as a number, not only my glucose?
    • Can the clinician treating my gut and the one treating my mood see each other’s notes?
    • How many antibiotic courses have I had in recent years, and is that written into my history?

    Nothing here is a reason to stop or adjust a psychiatric medication. That decision stays between you and the physician who prescribed it. Food still belongs in the conversation: in the SMILES trial of adults with major depression, remission rates were 32.3 percent with dietary support and 8.0 percent with social support. That sits alongside the prescription, not in place of it.

    Every study behind these figures, including the genetic work that argues against this model, is laid out in the Chapter 1 Deep Dive for The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. If you missed the start of the series, read what a vagus nerve test can and cannot show, then continue to what else is in the pill you already take.

    Frequently asked questions

    Can inflammation cause anxiety?

    It can contribute in some people. Endotoxin experiments lower mood in healthy volunteers, people who start out more anxious or stressed react more strongly, and in mice activated gut-lining cells produce anxiety-like behavior. It is not the cause for everyone, which is why measuring inflammation matters more than assuming it. Read what a test result can and cannot tell you.

    What CRP level suggests low-grade inflammation?

    Mood research commonly uses a CRP above 3 mg/L to define low-grade inflammation, and one anti-inflammatory trial found benefit only above 5 mg/L. Those are research cutoffs. CRP also rises with infection, injury or hard exercise, so a single high result should be repeated and explained before anyone reads meaning into it. See how to read your Measura report.

    Does gut serotonin affect anxiety?

    Not by traveling to the brain. Most serotonin is produced in the gut, yet that molecule is kept out of the brain by the blood-brain barrier. Gut signals reach the brain through vagal nerve fibers, and inflammation diverts tryptophan, the raw material the brain needs to make its own serotonin. Learn about autonomic symptoms and what they can signal.

    Can Measura test for leaky gut or my microbiome?

    No. Stool, breath and microbiome tests are separate services done elsewhere, and a widely used commercial zonulin kit was found to detect a different protein than the one named on its label. Measura measures metabolic and inflammatory blood markers, body composition, autonomic function and cognition, and reports them to your physician. See what Measura actually measures.

    Should I stop my anxiety medication if my inflammation is high?

    No. A raised inflammatory marker does not justify dropping or adjusting psychiatric treatment by yourself. The medication has a job, and any change is a decision with the physician who prescribed it. Measured inflammation adds a second line of work, often around insulin, weight and diet, rather than replacing the first. See insulin resistance and metabolic health.

    Can stress cause inflammation?

    Strain in daily life shows up in the blood. In healthy married couples, more hostile arguments went with more of a blood marker for bacterial fragments crossing the gut wall, and that marker tracked whole-body inflammation: 79 percent of people in its highest group had an average daytime CRP above 3, against 21 percent in its lowest. Diet adds fuel on top of that.

    What blood test checks for inflammation?

    The usual starting marker is C-reactive protein, or CRP, drawn as part of a laboratory panel chosen with your physician, often with fasting insulin beside it. One high CRP calls for a repeat, because infection, injury or a hard workout can also push it up. A blood test describes inflammation; it does not diagnose an anxiety disorder.

    Can diet help with inflammation and anxiety?

    Food belongs in the conversation. A food supply built on flour and sugar and stripped of fermentable fiber adds fuel to inflammation from the plate. In the SMILES trial of adults with major depression, remission rates were 32.3 percent with dietary support and 8.0 percent with social support. Diet sits alongside any prescription, never in place of it.

    Find out whether inflammation is part of your picture

    Ask your physician about metabolic and inflammatory blood work, body composition and autonomic testing, so the conversation about anxiety includes your own numbers.

    4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

    References

    • Irwin, M. R., Cole, S., Olmstead, R., Breen, E. C., Cho, J. J., Moieni, M., & Eisenberger, N. I. (2019). Moderators for depressed mood and systemic and transcriptional inflammatory responses: A randomized controlled trial of endotoxin. Neuropsychopharmacology, 44(3), 635–641. https://doi.org/10.1038/s41386-018-0259-6
    • Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R. (2012). Interferon-induced depression in chronic hepatitis C: A systematic review and meta-analysis. The Journal of Clinical Psychiatry, 73(8), 1128–1138. https://doi.org/10.4088/JCP.12r07694
    • Bayrer, J. R., Castro, J., Venkataraman, A., Touhara, K. K., Rossen, N. D., Morrie, R. D., Maddern, J., Hendry, A., Braverman, K. N., Garcia-Caraballo, S., Schober, G., Brizuela, M., Castro Navarro, F. M., Bueno-Silva, C., Ingraham, H. A., Brierley, S. M., & Julius, D. (2023). Gut enterochromaffin cells drive visceral pain and anxiety. Nature, 616(7955), 137-142. https://doi.org/10.1038/s41586-023-05829-8
    • Chen, Y., Xu, J., & Chen, Y. (2021). Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients, 13(6), 2099. https://doi.org/10.3390/nu13062099
    • Kiecolt-Glaser, J. K., Wilson, S. J., Bailey, M. L., Andridge, R., Peng, J., Jaremka, L. M., Fagundes, C. P., Malarkey, W. B., Laskowski, B., & Belury, M. A. (2018). Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation. Psychoneuroendocrinology, 98, 52–60. https://doi.org/10.1016/j.psyneuen.2018.08.007
    • Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019). Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels. Psychological Medicine, 49(12), 1958–1970. https://doi.org/10.1017/S0033291719001454
    • Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry, 70(1), 31–41. https://doi.org/10.1001/2013.jamapsychiatry.4
    • Nikolova, V. L., Smith, M. R. B., Hall, L. J., Cleare, A. J., Stone, J. M., & Young, A. H. (2021). Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis. JAMA Psychiatry, 78(12), 1343–1354. https://doi.org/10.1001/jamapsychiatry.2021.2573
    • Scheffler, L., Crane, A., Heyne, H., Tönjes, A., Schleinitz, D., Ihling, C. H., Stumvoll, M., Freire, R., Fiorentino, M., Fasano, A., Kovacs, P., & Heiker, J. T. (2018). Widely used commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Frontiers in Endocrinology, 9, 22. https://doi.org/10.3389/fendo.2018.00022
    • Jacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chatterton, M. L., Brazionis, L., Dean, O. M., Hodge, A. M., & Berk, M. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Medicine, 15(1), 23. https://doi.org/10.1186/s12916-017-0791-y

    Related reading